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CHAPTER I 
INTRODUCTION 
Breast cancer is the second leading cause of cancer 
death in women in the United States. An estimated 182,000 new 
cases of breast cancer will occur during 1993 (ACS, Facts & 
Figures, 1993). This disease is the most prominent cause of 
death for women 35-54 years of age (Goodman, 1987). Breast 
cancer is slowly increasing in incidence and prevalence. 
(Incidence is the number of new cases of disease in a 
particular time period. Prevalence is the number of existing 
cases of disease in a particular time period). In 1963 the 
incidence of breast cancer was 1 in every 18 women with an 
estimated life span of 72 years (Shimkin, 1963). Breast 
cancer incidence rates have increased about 3% a year since 
1980, going from 84.8 per 100,000 in 1980 to 109.5 per 100,000 
in 1988. Some of the increase is believed to be due to 
screening programs detecting tumors before they become 
clinically apparent. Other reasons for the increase are not 
fully understood at this time. Based on the number of new 
cases of breast cancer in 1993, it is estimated that 46,300 
deaths (46,000 women; 300 men) will occur. Only lung cancer 
leads as a cause of death in women. 
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Overview of Breast Cancer 
When discussing breast cancer, it is important to 
understand the common statistics used in relation to risk 
factors and breast cancer research. There are three types of 
risk: absolute risk, relative risk and attributable risk 
( Love , 1991 ) . 
Absolute risk is the rate cancer occurs in the general 
population. It is usually reported as a number per 100,000 in 
a given time period, or is reported as a cumulative risk up to 
a particular age. This is a number that can not be applied to 
any one individual. The risk for breast cancer is often 
explained as a cumulative risk. For example, approximately 
one of every 9 (and possibly one of every 8) women will 
develop breast cancer during a lifetime. This number is 
figured on a 1 i fetime cumulative risk, based on risk in a 
given population from age 20-30 plus age 30-40, and so on. 
With a lifetime cumulative risk, the longer a person lives, 
the higher the risk. With most cancers, this risk increases 
with age (Kelly, 1987). These numbers do not mean that if 
there is a room of nine women, one of these women will develop 
breast cancer. 
According to the American Cancer Society (ACS) 
calculations, the average Caucasian woman in the U.S. in 1988 
had a 10 percent risk of developing breast cancer. This 10 
percent risk is the lifetime cumulative risk for all white 
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women, which means a risk from the time of a woman's birth 
until she reaches 110 years of age. So only if a woman were 
to live to age 110 would her risk be 10 percent. 
The second type of risk when discussing breast cancer is 
relative risk. This is the comparison of the incidence of 
breast cancer among people with a particular risk factor to 
people without that factor. 
Risk Factors 
The term "risk factor" refers to identifiable factors that 
make some people more susceptible than others to a particular 
disease, for example, smoking is a "risk factor" in lung 
cancer, and high cholesterol is a risk factor in heart disease 
(Love, 19 91 ) . 
In general the principle risk factors for breast cancer 
include age, family history and menstrual and reproductive 
history (Harris, Hellman, Cannellos & Fisher, 1985). 
Specifically, the most important factors influencing a woman's 
likelihood of developing breast cancer include: advancing age, 
history of a previous breast cancer and a history of breast 
cancer in a mother or sister diagnosed before menapause 
(Stoll, 1991). 
Age: woman's risk at any one time depends on the extent of the 
woman's age. For the average Caucasian woman, it is 
approximately 1/1000/year at age 40, · or 0 .1 percent. This 
number increases with age, because breast cancer becomes more 
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common as women get older. For example, at age 50 the average 
Caucasian woman has a 1/500/year, or 0.2 percent risk of 
developing breast cancer (Love, 1991). Table 1 and Table 2 
contains the specific details. 
Table 1. 
The Average Risk of Developing Breast Cancer in a Given Year 
in White Women * 
Age Risk Per Year 
30 1 in 5,900 
35 1 in 2,300 
40 1 in 1,200 
50 1 in 590 
60 1 in 420 
70 1 in 330 
80 1 in 290 
*Adapted from P.C. Stomper, R.S. Gelman, J.E. Meyer and 
G.S. Gross, "New England Mammography Survey 1988: Public 
Misconceptions of Breast Cancer Incidence," Breast Disease, 
May, 1990. Reprinted with permission. 
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Table 2. 
Probability of a Woman Developing Breast Cancer by age 75 * 
Ethnic Group % Number 
Caucasian 8.2 1 in 12 
African-American 7.0 1 in 14 
Chinese- American 6.1 1 in 16 
Japanese-American 5.4 1 in 19 
New-Mexican Hispanic 4.8 1 in 21 
American Indian 2.5 1 in 40 
* J.W. Berg, (1984) "Clinical Implications of Risk Factors for 
Breast Cancer," Cancer ~' 589. Reprinted with permission. 
The highest incidence of breast cancer occurs in women 
between the ages of 50-59 (Sakamoto & Sugano, 1981). The 
second peak incidence occurs in women between 65-69 years of 
age (Goodman, 1987). 
Family History: in addition to advancing age, heredity (family 
history) is considered another major risk factor. Women who 
have a first-degree relative (mother or sister) with breast 
cancer have a risk two or three times that of the general 
population. This risk is further increased if the relative is 
diagnosed at an early age or had bilateral disease. The risk 
of breast cancer in women with both an affected mother and 
sister is about 6.5 times greater and significantly different 
(p < .005) than that in women with either an affected mother 
or sister alone (Sattin, Rubin, Webster, Huezo et al, 1985). 
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This risk translates into a 50 percent probability of 
developing breast cancer by age 65 for women with an affected 
mother and sister (Swartz, 1982). These numbers however must 
be kept in perspective. 
Genetically, we di vi de breast cancer occurrences into 
three groups. According to Love (1991), the first and most 
common type is sporadic. This group includes the 70 percent 
of women who have no known family history of the disease. The 
second group of breast cancer occurrences is genetic, where 
there is one dominant cancer gene that is passed on to every 
generation. This type of pure hereditary breast cancer is 
rare, but does occur. Only between 5 and 7 percent of all 
breast cancers fall into this category (Love, 1991), 
Love (1991) reports that "most people assume that these 
are the only two kinds of breast cancer: the kind that is 
inherited and the kind that is not" (Love, 1991, p. 146). 
However there is a third group that is much more common than 
the genetic group. This is the "polygenic" category, in which 
there is a family history of breast cancer that is not 
directly passed 
gene, but will 
on to each generation through one dominant 
affect some members of the family and not 
affect others (Love, 1991). 
Even though most breast cancers occur in women with no 
known history, it is clear that a family history is still 
considered a major risk factor for developing the disease. 
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Menstrual and Reproductive History: The third major risk 
factor for developing breast cancer is hormonal. Hormones 
play a key factor in breast cancer because it is a common 
cancer in women and rare in men. At this point in time, there 
is not a full understanding of how the hormonal factor plays 
out, but there are some interesting clues, There is an 
association between age and menstrual cyclying. The younger 
a woman is when she begins menstruating, and the older she is 
when she begins menopause, the more likely she is to develop 
breast cancer. It appears that the more periods a woman has 
over her lifetime, the more prone she is to develop breast 
cancer (Love, 1991). Castration either by surgery or 
radiotherapy, substantially reduces a woman's risk of getting 
breast cancer (MacMahon, Cole & Brown, 1973; Tuchopoulos, 
MacMahon & Cole, 1968). If the castration occurs early (prior 
to 35 years of age) with removal of the ovaries, the risk of 
cancer is reduced to one third of that experienced by women 
who have a natural menopause (Harris, Hellman, Cannelos & 
Fisher, 1985). 
A strong association exists between breast cancer and 
pregnancy. Nulliparous women (those who have never had 
children) appear to be more at risk than women who have had 
children. Women who have their first child before the age of 
18 have only one third the breast cancer risk of those whose 
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first child is born after 30 years of age (Harris et al, 
1985). However, this does not appear to apply to pregnancies 
that are terminated because of miscarriage or abortion 
(Rosenberg, Palmer, Kaufman, Strom, Schottenfeld & Shapiro 
(1988). Women who have their first child after age 30 
actually have significantly higher risk than do women who 
remain nulliparous (Henderson, Pike & Gray, 1981). 
Early Detection 
The 5-year survival rate for localized breast cancer has 
risen from 78 percent in the 1940's to 92 percent today (ACS, 
Facts & Figures, 1992). The survival rate is directly related 
to the size of the breast lesion. The larger the tumor, the 
greater the chance that metastases have occurred. Once breast 
cancer occurs or spreads beyond the breast it is a lethal 
disease. Therefore, early detection of breast cancer remains 
a vital key to increased cure rates and survival. 
There are three established methods of early detection of 
breast cancer: physical examination, breast self-examination, 
(BSE) and mammography. Mammography is a radiographic technique 
to detect non-palpable cancers. Eighty-five percent of breast 
cancers will be detected by mammography and up to 50 percent 
of these will be nonpalpable (Beahrs, Shapiro & Smart, 1979). 
However routine screening with mammography has not been 
recommended for women under age 40 for several reasons. 
First, mammography has less diagnostic accuracy in this age 
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group because of increased density of the normal breast 
tissue. Second, concern still exists over repeated low dose 
radiation exposure over many years. Further the incidence of 
breast cancer below age 40 is low compared to the cost of the 
procedure. Therefore, physical examination by experienced 
medical personel and BSE is advised especially in younger 
women. 
Breast self-examination (BSE) is recommended by the 
American Cancer Society (ACS) on a monthly basis for all women 
over age 20. BSE is a simple and safe procedure without cost 
to women who practice it. In a study of over 2000 women 
Huguley and Brown (1981) found that the more frequently women 
performed BSE, the more likely BSE was successful as being the 
first method to detect cancer. When cancer was discovered by 
BSE it was at an earlier stage than after all other methods of 
detection except mammography. This finding indicates that the 
practice of BSE can play an important role in early diagnosis 
of breast cancer. Improvements in the practice of BSE may 
reasonably be expected to impact on survival of women with 
breast cancer. 
This limited background on the subject of breast cancer 
serves as a foundation for this study. With a better 
understanding of this disease, health psychologists can play 
a major role in designing better methods to educate all women 
about risk factors, to promote the importance of early 
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detection in this disease and to identify high-risk 
individuals who need increased awareness and education about 
their risk. 
As a way of narrowing the focus of such a broad and 
complex problem, this research will examine a group of women 
toward whom little attention has been directed, that is toward 
daughters who have a maternal history of breast cancer. 
Theoretical Rationale 
A theoretical model which best addresses the health 
behavior of this population is the Health Belief Model (HBM). 
This model was devised in the early 1950's by Levanthal and 
colleagues (a group of social psychologists at the United 
States Public Health Service) in an attempt to understand the 
"widespread failure of people to accept disease preventives or 
screening tests for the early detection of asymptomatic 
disease" (Rosenstock, 1974, p. 328). It was later applied to 
patients' responses to symptoms (Kirscht, 1974) and to 
compliance with prescribed medical regimens (Becker, 1974). 
Since 1974, the HBM has continued to be an organizing 
framework for explaining and predicting acceptance of health 
and medical care recommendations. It has been applied to a 
wide range of health behaviors including smoking, dietary 
changes and cervical and breast cancer screening compliance. 
Specifically the HBM consists of three dimensions. It 
predicts that preventive health actions will more likely be 
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performed by individuals who (1) perceive susceptibility to a 
disease and (2) perceive the severity of the disease; and (3) 
perceive the benefits of the preventive health actions to 
outweigh the cost of doing such action. Thus, "The combined 
levels of susceptibility and severity provide the energy or 
force to act and the perception of benefits (minus the 
barriers) provide a preferred path of action" (Rosenstock, 
1974, p. 332). 
In 1977 Bandura introduced the concept of self-efficacy as 
a distinct outcome expectation (Bandura, 1977a, 1977b,1986), 
which, based on present health behavior research, needs to be 
included in the HBM in order to increase its explanatory power 
(Rosenstock, Strecher & Becker, 1988). Self-efficacy is 
defined as "the conviction that one can successfully execute 
the behavior required to produce the outcomes (Bandura, 1977a, 
p. 79). Therefore, for behavior change to succeed, individuals 
must (as the original HBM theorizes) feel threatened by their 
current behavioral patterns (perceived susceptibility and 
severity) and believe that a change in action will be 
beneficial (outweigh the cost), 
competent (self-efficacious) to 
(Rosenstock, 1990). 
but they must also feel 
implement the change 
Several recurrent critiques continue to surface against 
the utility and validity of the HBM. The major criticism is 
that the notion of a belief-behavior relationship has never 
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been uniformily established. Rosenstock (1990) argues "what 
would seem to be needed is further research to specify the 
conditions under which speci fie beliefs and behaviors are 
causally related and the conditions under which they are not" 
(Rosenstock, 1990, p. 48). 
A second critic ism is that the HBM does not address 
strategies for change in behaviors. However, the originators 
of this model argue that this was not its purpose. Rosenstock 
(1990) comments that "overenthusiastic proponents of the HBM 
may on occasion have attempted to explain more than such a 
model could possibly explain" (p. 49). It has been pointed 
out that "the HBM is a psychosocial model and as such, it is 
limited to accounting for as much of the varience in 
individuals' health-related behaviors as can be explained by 
their attitudes and beliefs. It is clear that other forces 
influence health actions as well" (Janz and Becker, 1984, 
p. 44). 
Table 3. 
Key Components of the Health Belief Model 
I. Threat 
A. Perceived susceptibility to an ill-health 
condition (or acceptance of a diagnosis) 
B. Perceived severity of the condition 
II. Outcome expectations 
A. Perceived benefits of specified action 
B. Perceived barriers to taking that action 
III. Efficacy expectations 
A. Conviction about one's ability to perform the 
recommended action (self-efficacy) 
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Note: Sociodemographic factors such as education, age, 
gender, ethnicity and income are believed to influence 
behavior directly by affecting perceived threat, outcome 
expectations and efficacy expectations. Used with permission. 
Rosenstock (1990). 
Kasl and Cobb ( 1966) define heal th behaviors as "any 
activity undertaken by a person believing himself to be 
healthy, for the purpose of preventing disease or detecting it 
in an asymptomatic state". Harris and Guten ( 1979) have 
expanded this definition to include health-promoting and 
heal th maintaining behaviors as well as disease-preventing 
behaviors and have labeled these "health-protective 
behaviors". Attempts to predict the performance of these 
health-protective behaviors have relied on the Health Belief 
Model. 
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Perception of Risk 
In health psychology one of the primary concerns is the 
way individuals respond to and cope with threats and stresses 
posed by sickness and health care (Stone, 1979). Current 
concepts of illness behavior and health protective behaviors 
place an emphasis on cognitive factors. An example of these 
factors can be seen in the continued expansion of the Health 
Belief Model to include the concept of the "at risk role" 
described by Barie (1969). The individual at risk is 
somewhere in the middle of a state of health and the state of 
experiencing symptoms. People "at risk" include those who 
perform certain activities (i.e. smoking) which increases 
their risk of illness to a much higher degree than that of the 
general population. The risk however must be perceived as 
such for it to have an impact on the decision-making of the 
individual at risk (Stone, 1979). 
This perception of risk is discussed by Wallston and 
Wallston, (1982) as the "readiness to take a health action". 
This "readiness" is determined by (1) the person's perceived 
likelihood of susceptibility to a disease (such as having a 
mother with breast cancer) and (2) by the individual 
perceiving the severity and the consequences of developing a 
particular illness, (such as having a mother who has gone 
through treatment for breast cancer). These two factors, the 
susceptibility and severity comprise the perceived threat of 
15 
the disease. Once an individual identifies the threat, then 
health behaviors (such as BSE and mammography) are likely to 
be evaluated both for their potential benefit and for whether 
performing these health behaviors outweigh the costs. A cue 
to action, (such as a health education message) will enhance 
the likelihood of performing these health behaviors. 
The Heal th Belief Model has been applied to several 
studies looking at health beliefs and attitudes, and breast 
cancer screening. Lermer, Rimer & Engstrom ( 1989) review 
several studies that relate to the HBM and breast cancer 
screening. For example, Slenker and Grant (1989) found that 
the more strongly a woman believed in the benefits of 
mammography, and the less concern she reported toward the 
"barriers" or costs, the more likely she was to have had a 
mammogram or to say that she intended to have a mammogram. In 
another study, Calnan (1984), identified beliefs in the 
efficacy of mammography and the potential curability of breast 
cancer as factors that related to obtaining mammograms. In 
addition, an earlier study by Fink, Shapiro & Roester (1972) 
found that regular participation for breast cancer screening 
was associated with increased perceptions of susceptibility to 
breast cancer. However, Rimer and colleagues (1988) have 
reported opposite findings. In addition, another study that 
looked at beliefs and breast cancer screening also identified 
"barriers" or costs which women report as reasons for not 
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obtaining mammography, such as financial constraints, fear of 
radiation exposure and inconvenience (Fox, Baum, Klos & Tsou, 
1985). 
Al though the Heal th Belief Model attempts to explain 
factors which influence individuals to take action so as to 
prevent, detect and diagnose disease, there is the option of 
reacting to the threat of breast cancer, for example, with the 
use of negative coping mechanisms. These might include, for 
example, the use of denial in which case women with a maternal 
history of breast cancer may not perceive an increased risk to 
themselves, and may not take part in any health-protective 
behaviors such as BSE and mammography (Disch, 1987; Taylor, 
1987). Secondly, individuals may feel terrified at the 
thought of getting breast cancer and may take on obsessive-
compulsive behaviors or become extremely anxious and phobic 
about the disease. 
Significance of the Study 
Breast cancer is the most common cancer in women. The 
emotional, social and medical needs of women with breast 
cancer have been increasingly recognized and studied in the 
last few years. Patients with breast cancer are so profoundly 
affected by their disease, it is not surprising that their 
families are also deeply affected. However, few articles 
exist which address specific family members. Given the 
limited amount of investigation, it seems timely to look at 
the daughters of women with breast cancer. 
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Since little is 
known concerning their awareness of risk, their knowledge of 
breast cancer, their psychological issues and whether or not 
they practice health-protective behaviors, a randomized, 
controlled study was needed to address these issues more 
objectively. Using the Health Belief Model as a theory base 
and recognizing the potential severity and chronici ty of 
breast cancer, it was appropriate to specifically address the 
issues of awareness of risk, knowledge of breast cancer, 
psychological factors that may be affecting the daughters and 
the practice of heal th behaviors in young women with a 
maternal history of breast cancer. With an increased 
understanding of breast cancer and these issues, health 
psychologists will be better able to address the issues of 
education and promotion of health to women in general and to 
those at a higher risk of breast cancer. 
Purpose of the Study 
This study identified a high risk population of women in 
developing breast cancer (those with a maternal history of 
breast cancer). With breast cancer specifically, it is likely 
that daughters will be emotionally affected by the chronicity 
of the disease of their mothers. However, despite their 
sensitization, they may or may not develop a sense of being at 
risk themselves. Extending the Health Belief Model to such 
women, one would assume that daughters of women with breast 
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cancer would (1) have an accurate sense of their own risk for 
breast cancer, (2) have an accurate knowledge base about the 
disease and (3) pratice health-protective behaviors to 
minimize the risk. However these hypotheses have not been 
tested. The purpose of this randomized, controlled, 
intervention study was to identify in women with a maternal 
history of breast cancer (1) their knowledge base about breast 
cancer, (2) an awareness of the risk to self, (3) identify 
psychological factors that may or may not be affecting these 
women, (4) to identify any behaviors that might minimize their 
risk and (5) to investigate the impact of a didactic group 
experience on these women who potentially have a high risk of 
developing breast cancer. 
Summary 
Chapter One highlights information about breast cancer 
including incidence, risk factors, early detection and 
screening for breast cancer. This background served as a 
foundation for the theoretical framework consisting of the 
Health Belief Model. This framework included a discussion of 
current concepts related to illness and health behaviors and 
how these relate to the "at risk" role. The significance and 
purpose of the study are then presented. 
Chapter Two will be a review of selected literature 
concerning the psychosocial impact of breast cancer on women 
with a maternal history of disease. 
19 
Chapter Three will include the methodology including the 
design, subject selection, instrumentation, procedural details 
and treatment of the data from the questionnaires, pre and 
posttests and standardized measures. 
Chapter Four will describe the analysis of data and 
discussion of those results. 
Chapter Five will include the limitations of the study, 
the summary, discussion, conclusion and implications for 
health psychology and future research. 
CHAPTER II 
REVIEW OF THE LITERATURE 
Psvchosocial Impact of Breast Cancer on Daughters 
Women with a first-degree relative (a mother or sister) 
who have had breast cancer have a risk for breast cancer two 
to three times the risk of the general population (Sattin and 
colleagues, 1985; Byrne, Brinton, Haile and Schairer, 1991). 
Over the last twenty years, the literature has addressed the 
biological and psychological components related to the 
individual with breast cancer. Because women with breast 
cancer are significantly affected by the disease, it would be 
surprising if their family members were not also affected 
(Kelly, 1980). In the past the literature regarding the 
impact of breast cancer on the family has been limited to a 
very general focus. Specific family members, such as 
daughters, have received insufficient attention by 
researchers. Given the potential identification and closeness 
of mothers and daughters, the impact of breast cancer may be 
significant for the daughters. This chapter will review the 
literature on the the impact of breast cancer on the daughters 
whose mothers have breast cancer. 
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Several early studies have addressed the impact of 
breast cancer on the family in a very descriptive and general 
fashion. 
One of the earliest studies in the literature to report 
on the impact of breast cancer on family members is by 
Grandstaff (1976). The author conducted interviews and 
counseled patients recently diagnosed with breast cancer and 
their families pre and post surgery. The author reported that 
teen-aged or older daughters "usually identify quite closely 
with their mother" and because of this shared experience, the 
daughters may assume the major "support role" (p. 153). The 
author concludes from the interviews that many of the patients 
express feelings of guilt regarding the potential development 
of breast cancer in their daughters. And the daughters 
reported a "considerable amount of fear toward develping 
breast cancer" (Grandstaff, 1976). This study, al though 
methodologically weak, represents one of the first reports of 
the emotional impact that breast cancer might inflict upon 
daughters. 
Lewis, Ellison and Woods (1985) discussed selected 
concepts that characterize the impact of breast cancer on the 
family, primarily as the illness relates to the day-to-day 
operations of family life; for example: the family's 
adaptation style, characterized with such themes as 
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powerlessness, uncertainty, interdependence, ambivalence, role 
restructuring and resilency (Lewis, Ellison and Woods, 1985). 
The second half of this research reported on a 
longitudinal study looking at 126 families whose mothers had 
nonmetastatic breast cancer. Discussion focused on initial 
at-home interviews with the mother, her partner and school-
aged children. The authors examined the data for differences 
in responses according to the children's stage of psychosocial 
development. The adolescent group (14-19 years of 
provided some of the "most provocative interviews" (p. 
illustrating significant conflict for the adolescents. 
age) 
209)' 
For 
example, "they spoke of being torn between wanting to spend 
time with their mother and wanting to 'do their own thing'" 
(Lewis, Ellison and Woods, 1985, p. 209). 
Wellisch, Mosher and Van Scoy (1978) have also reported on 
observations of children, although the study did not focus 
specifically on breast cancer. The authors observed that 
children who have a parent with cancer have frequently 
attended their family therapy group sessions. They found that 
the children are very reactive to cancer in a parent but are 
far less verbal than adults. 
This study was a retrospective clinical account of six 
adolescents and their need for psychological interventions 
because of problems which occurred due to the dianosis of 
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cancer in a parent. The authors hypothesized that as a 
reaction to the cancer in a parent, the adolescents acted out 
in maladaptive ways. Some developed problems in school or 
became disciplinary problems in an unconscious attempt to 
refocus the attention of family from the cancer onto their own 
problems. 
Overall, the stresses for adolescents whose parents have 
cancer can be extremely intense. The authors discussed the 
developmental phase of adolescence, specifially the normal 
processes of "gradual emotional withdrawal and intensi f ica ti on 
of relationships outside the family system that should occur. 
Cancer in a parent will disturb or reverse this process" 
(p. 230). 
The authors also discussed observations seen in children 
in their late teens and early twenties who found themselves 
"placed in the role of emotionally parenting their frightened 
and regressed parents before they felt adequately prepared to 
do so" (Wellisch, Mosher and Van Scoy, 1978, p. 230). 
Berman, Cragg and Kuenzig (1988) assessed the reactions 
of ten adolescents and their reactions to the death of a 
parent from cancer, again, not specifically for breast cancer. 
The adolescents and their surviving parent were evaluated 
using a semi-structured questionnaire looking at communication 
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patterns and support systems for the adolescents. The authors 
reported that all ten families kept the adolescents well 
informed about the parent's illness from the time of diagnosis 
to death. Similiar reporting of important events like 
diagnosis, death and funeral were found between adolescent and 
parent. However, there was disagreement between parents and 
adolescents on identified sources of support. Parents 
identified physicians and school personnel as their greatest 
sources of support, while adolescents identified family 
friends 1 relatives and peers as their greatest sources of 
support. The adolescents reported little or no help or 
support from health care professionals and reported feeling 
isolated especially when the parent with cancer was in a 
terminal phase of the illness (Berman, Cragg and Kuenzig, 
1988). 
Rosenfeld and colleagues (1983) addressed the issues of 
adolescents specific to the impact of breast cancer. The 
authors reported on a pilot retrospective, exploratory study 
from Israel of eight adolescent daughters whose mothers had 
breast cancer. A structured interview format conducted by a 
clinical psychologist and a pediatrician trained in child 
psychiatry was used in obtaining information from the 
adolescent girls. The authors reported that "most girls were 
significantly upset, felt inadequately supported and lacked 
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information during periods of peak stress caused by the 
illness and its treatment" (p. 244). The authors observed no 
maladaptive behaviors in this group of adolescents. 
A dissertation by Lamb (1984) also addressed problems and 
concerns of adolescent girls' responses to their mothers' 
breast cancer. An open-ended, semi-structured interview was 
conducted with 10 adolescent girls between 13 and 17 years of 
age. The purpose of this study was to identify the impact of 
a mother's breast cancer in several areas including: perceived 
changes in the family system, somatic concerns, relationship 
issues and coping styles. A case study format was used to 
report findings. The major theme expressed by all daughters 
was that of anxiety about a possible recurrence of cancer in 
their mother, as well as concerns about developing breast 
cancer themselves. In addition, a large number of somatic 
concerns were reported by many of the girls. The author 
reports that the overall coping style was one of denial and 
avoidance, which appeared to be successful adaptations to 
control the anxiety about their mothers' illness. No major 
mood disorders or acting out behaviors were observed, however 
one subject demonstrated a depressed affect (Lamb, 1984). 
This next study to be reviewed addressed relationship 
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issues between women with breast cancer and their daughters 
and sons. Lichtman and colleagues (1984) describe a study in 
which 78 patients with breast cancer were interviewed and 
completed standardized measures to assess psychological 
adjustment and to document perceptions of changes in their 
relationships with their children. Although the majority of 
mother-child relationships were reported to be strong or to 
have become stronger, twelve percent of those studied had a 
deterioration in their relationship. 
prognosis, more severe surgery, 
Mothers who had a poor 
poorer psychological 
adjustment, and to a lesser degree had more difficulty with 
chemotherapy or radiation therapy were more likely to have 
problems with their children. The authors report that: 
The mothers' relationship with their daughters were at 
significantly greater risk than were the relationships 
with their sons. Seventeen percent of the patients 
studied reported that their daughters were withdrawn, 
fearful, hostile or rejecting; only eight percent of 
women reported having problems with their sons (p. 1). 
Several contributing factors to the difficulties with 
adolescents or post-adolescent daughters included: fear of 
inheriting breast cancer and mothers' demands on the daughters 
for support (Lichtman and colleagues, 1984). 
Several studies have been reported that address more 
specific issues of women with a maternal history of 
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breast cancer. Kelly (1980) used a semistructured interview 
designed to elicit what thirty-nine women with a maternal 
history of breast cancer thought, felt and did about breast 
cancer and health practices specific to breast cancer. Each 
woman reported they were profoundly affected by their mother's 
illness. They expressed ''feelings of guilt and anxiety which 
came about after their mother's diagnosis. Many felt 
chronically threatened by breast cancer. Although the women 
were concerned about risk, they had only vague and sometimes 
incorrect information about the significance of the risk" 
( Ke 11 y, 198 0 , p. 118 ) . 
Al though these studies represent some of the first to 
specifically address daughters of women with breast cancer, 
there are significant methodological weaknesses including: 
very small sample size, absence of control groups, and little 
or no use of standardized measures. The conclusions drawn 
strongly emphasize the anxiety issues and lack of accurate 
information and support that these women experience. 
Based on previous research (Kelly, 1980), Kelly embarked 
on a new approach and reported on experiences of risk 
counseling for relatives of individuals with cancer (Kelly, 
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198 7). The process of risk counseling presents various aspects 
of cancer risk analysis, which provides information about the 
social, scientific and medical factors that can affect 
individuals who have a family member with cancer. The premise 
of the service is that accurate information increases a sense 
of empowerment. The service provides individuals with the 
opportunity to explore their own and other family members' 
risks of developing cancer. The author reports specific 
accounts of women seeking cancer risk analysis whose mother or 
sister has breast cancer. Kelly advises that the information 
be given as part of an ongoing process, not in a hurried 
single visit. When people are anxious and confused, they need 
more information, not less. The expected outcome is that 
information will relieve anxiety and help relatives of persons 
with cancer to function more effectively (Kelly, 1987). 
Kash, Holland, Halper and Miller (1992) investigated 
the beliefs of women at high risk for breast cancer regarding 
their own breast cancer risk and the impact of this 
information on their psychological distress and the health 
behaviors they practice. Two hundred seventeen women were 
evaluated based on multiple instruments measuring anxiety, 
coping styles, social support, social desirability and health 
behaviors practiced. The results of their study found that 
women who perceived (1) a high risk for breast cancer, (2) had 
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high anxiety levels and (3) felt they could do little about 
developing breast cancer were less compliant with heal th 
behaviors such as BSE and mammography screening. Another 
major finding in this study was that mean levels of 
psychological distress (based on Brief Symptom Inventory) 
among these women exceeded normal ranges by almost one 
standard deviation. The authors conclude that a psychological 
and educational intervention aimed at reducing anxiety is 
greatly needed for this group of women with a maternal history 
of breast cancer. 
Wellisch, Gritz, Schain, Wang and Si au (1991) 
investigated differences between daughters of women with 
breast cancer and a matched control group (women without a 
family history of breast cancer) in several areas including: 
(1) knowledge and attitudes about breast cancer, (2) health 
behaviors, (3) quality of mother-daughter relationships, (4) 
sexuality and body image, and (5) two areas of psychological 
functioning which included symptomatology and coping 
behaviors. The researchers utilized a structured interview, 
written questionnaires and standardized instruments including: 
(1) Brief Symptom Inventory, (2) Derogatis Sexual Functioning 
Inventory, ( 3) Sexual Arousabili ty Inventory, ( 4) Ways of 
Coping Checklist to gather information from 120 women. The 
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authors conclude that the "most important finding is the 
lack of differences between daughters of women with breast 
cancer and the well-matched comparisons" (p. 332). Overall, 
no differences between groups were found in psychological 
symptoms, coping styles, BSE and mammographic screening 
practices, heal th knowledge or body-image ratings, These 
results are in contrast to the previous studies reviewed in 
that these women with a breast cancer history "showed good 
overall coping styles with few signs of significant 
dysfunctions in relation to the control group" (p. 324). One 
major area of difference was that women with a maternal 
history of breast cancer "showed significantly less frequent 
sexual intercourse, lower sexual satisfaction and greater 
feelings of vulnerability to breast cancer and they 
identified a greater number of symptoms of breast cancer" 
(p. 324). 
In Part II of the above study, Wellisch, Gritz, Schain, 
Wang and Siau ( 1992) explored the characteristics of the 
distressed daughter of a woman with breast cancer. The 
authors determined that the two major variables that were most 
likely to influence psychological adjustment were (1) 
daughter's developmental phase (age at the time of her 
mother's diagnosis), and (2) mother's survival status. Of the 
60 daughters with a history of breast cancer, 30 were selected 
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whose mothers were living and 30 were selected whose mothers 
had died. The daughter's age at the time of her mother's 
diagnosis was divided into three categories: 
(1) childhood (0-10 years, n=9, 15% of the sample), 
(2) adolescence (11-20 years, n=15, 25% of the sample), 
(3) adulthood (older than 21 years, n=36, 60% of the sample). 
The results showed that adolescent daughters "reported feeling 
significantly more uncomfortable about involvement in their 
mothers' illness" (p. 171) than the adult daughters. 
Overall, the daughters who were adults at the time of 
their mother's diagnosis had the least adjustment problems, 
daughters who were children had moderate adjustment problems 
and daughters who were adolescents had the greatest adjustment 
problems. 
Based on the daughter's age at the time of her mother's 
diagnosis, the subjects were divided into two groups (0-20 and 
+20 years) and compared on the basis of mother's survival. The 
younger daughters (0-20) at the time of mother's diagnosis, 
were "significantly more likely to have mothers who died of 
their disease" (p. 175). Daughters whose mothers had died 
were "more likely to report (1) long-term life plan changes 
and (2) role changes with their mothers during the mothers' 
illness" (p. 171). The authors also point out that 
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psychological symptomatology as measured by the Global Symptom 
Index (from the BSI) could be predicted by three variables: 
"(1) issues of discomfort with involvement with the mother 
during her illness, (2) lack of resolution about their 
mother's illness and ( 3) lack of satisfaction with sexual 
intimacy" (p. 178). The authors are quick to point out that 
replication studies are needed for several reasons: this is 
primarily retrospective data and the demographics of this 
group of daughters in terms of SES, education and ethnicity 
"are not representative of the entire population". However 
this study identifies a subgroup of daughters who are less-
resol ved and more distressed about their mother's breast 
cancer, which stresses the importance of prospective studies 
that may help predict women at greatest risk for psychological 
distress (Wellisch, Gritz, Schain, Wang and Siau, 1992). 
Another study that investigates daughters of women with 
breast cancer is a dissertation by Dworsky (1990). The purpose 
of this study is to identify the effects of an educational 
program conducted through the mail that tests the following 
hypotheses: first, women with a family history of breast 
cancer will be more knowledgable and more fearful of breast 
cancer than women without a family history. Secondly, 
educational intervention conducted through the mail will 
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change beliefs, attitudes and health practices of women 
participating in this study by increasing knowledge, 
decreasing fear and will increase motivation to practice 
"preventive breast care". Participants included three hundred 
twenty-one women who had participated in two previous 
epidemiology studies of breast cancer: 190 women randomly 
selected as controls and 131 women who are daughters and 
sisters of premenopausal patients with bilateral breast cancer 
(therefore a high risk group). These women were then sent 
questionnaires looking at breast cancer knowledge and 
screening practices, and "breast fears including a 'personal 
happiness' inventory". Once pretest information had been 
returned the women were then sent four educational pamphlets 
from the American Cancer Society and National Cancer Institute 
and were asked to read, review and rate which best suited 
their own educational needs. One hundred sixty-four women 
completed and returned the posttests. The women were divided 
into two groups: women with a family history (N = 80) and 
women without a family history (N = 84). The study 
participants ranged in age from 20-75 years. The author 
summarizes the results as follows: women with a family history 
of breast cancer entered the study better educated (mean 
pretest score was 81.9 versus 74.9), although women without a 
family history scored higher on the posttest (mean score was 
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95.9 versus 92.8). Women with a family history reported being 
more fearful than those without a family history. The women 
with "high fear scores" tended to be younger, have a family 
history of breast cancer, less likely to have had a mammogram, 
and overall "more nervous, worried and less happy than women 
with lower fear scores". Of this "high fear" group, 47 percent 
reported that the educational program decreased their fear and 
were more interested in additional breast cancer information. 
Twenty-seven percent of the "high fear" group reported that 
the educational program increased their fear. 
Although methodologically weak in some areas, such as the 
lack of standardized measures, the above study represents a 
first step toward investigating educational interventions for 
women with a maternal history of breast cancer. 
In summary, Chapter Two highlighted a review of the 
literature addressing the impact of breast cancer on daughters 
with a maternal history of the disease. Clearly, the review 
of the above literature suggests a significant need for health 
care professionals to become more aware and involved in the 
needs of the entire family when caring for patients with 
cancer. 
Although these studies provide a first step in 
understanding the acute and chronic effects of breast cancer 
on individuals whose parent have the diagnosis, there are 
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significant methodological weaknesses, Most of the limited 
psychological, nursing or psychiatric literature report 
anecdotes, isolated case reports and clinical impressions 
(Grandstaff, 1976; Wellisch, Mosher and Van Scoy, 1978; Kelly, 
1980; Lamb, 1984). Only a few of the above studies used 
control groups or standardized measures (Kash, Holland, Halper 
and Miller, 1992; Wellisch, Gritz, Schain, et al, 1991) and 
only one study used randomization (Dworsky, 1990). 
Because of the complex issues surrounding the 
developmental phase of adolescence, the present study focused 
on women between the ages of twenty to forty. In addition, 
psychological factors may be more complex if women are dealing 
with the death of their mothers as well as the impact of the 
disease. Therefore, women were excluded from this study if 
their mothers had died of breast cancer. 
Based on this review of the literature of the impact of 
breast cancer on family members, specifically, daughters, this 
study will address several hypotheses: 
(1) There is no difference in knowledge about breast cancer 
between the experimental and control group immediately after 
attending breast cancer classes and 
at a follow-up time. 
(2) There is no difference in the awareness of risk for breast 
cancer to self between the experimental and control group 
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immediately after attending breast cancer classes or at a 
follow-up time. 
(3) There is no difference in psychological variables 
(anxiety, depression and somatization) between the 
experimental and control group immediately after attending 
breast cancer classes and at a follow-up time. 
( 4) There is no difference in heal th behaviors practiced 
between the experimental and the control group before or after 
attending breast cancer classes. 
CHAPTER III 
METHODOLOGY 
The purpose of this randomized, controlled study 
included: (1) to identify women with a maternal history of 
breast cancer, (2) to assess knowledge about breast cancer in 
this population, (3) to determine awareness of susceptibility 
to breast cancer in this "at-risk" group, (4) to examine the 
impact of information about breast cancer on psychological 
symptoms (i.e. anxiety, depression and somatization) of women 
attending two didactic group sessions compared to a control 
group (women not attending the classes), ( 5) to determine 
health-promoting behaviors practiced by these women, 
specifically early detection methods of screening for breast 
cancer. All women received an information sheet, signed a 
consent form, completed a standardized self-report measure 
SCL-90-R, 
post test. 
a pretest, demographic questionnaires and a 
Their responses provided both quantitative and 
qualitative data for analysis. 
The didactic group experience was piloted with five women 
who did not have a maternal history of breast cancer. They 
were recruited by the author and the R.N. who presented the 
didactic group classes. (See Appendix A, The Pilot Study), 
37 
38 
The classes were held two evenings, a Tuesday and Thursday 
from 6-8 pm. The pilot study determined the understandablility 
of the content of the class, the difficulty with the timing of 
the class, the scheduling of the content of the classes, and 
assessed acceptability of homework assignments and overall 
identified the strengths and weaknesses of the classes. Data 
obtained from this pilot study was descriptive in nature and 
resulted in frequency rates of rates of responses. 
Design of Study 
The design of this study is presented in 
Stanley ( 1963, p. 8) , the number four 
experimental designs", the Pretest-Posttest 
Campbell and 
design "true 
Control Group 
Design. The following is the diagram of the design. 
R 
R 
0 
0 
x 0 
0 
0 
0 
According to Campbell and Stanley (1963), the pretest-
posttest control group design "controls for all seven sources 
of possible threats to internal validity, specifically history 
maturation, testing, instrumentation, regression, selection, 
mortality and interaction of selection and maturation, etc". 
This is primarily accomplished because this design uses the 
process of randomization, a major strength of this study. 
Another strength of this study is that it added a follow-
up time (6-12 months) to evaluate for- lasting effects of the 
intervention. 
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Sub.iects 
There were a total of fifty-nine women who participated in 
this study. All women who participated had mothers living with 
breast cancer and were aware of their mothers' diagnosis. A 
computerized list of all women with the diagnosis of breast 
cancer was generated from both the Section of Medical Oncology 
and from the Tumor Registry of a large urban medical center. 
This list was then presented to the physicians of these women. 
If the women had Stage I or II breast cancer and were within 
an age range to have a daughter between 20 and 40 years of 
age, a letter was mailed to them informing them of this study. 
Those interested in receiving more information and/or willing 
to grant permission for this investigator to call their 
daughters, then signed a consent form (Appendix B) and mailed 
it to this investigator. The daughters were then contacted by 
telephone. If they met eligibility criteria (between the ages 
of 20 and 40 and have mothers living with breast cancer), then 
they were given a detailed explanation of the study, which 
included the concept of randomization. Those agreeing to 
participate were then randomized to attend two 2 hour classes 
or be placed on a wait-list control group with the option of 
attending the classes at a later time. 
Because not enough women agreed to participate in the 
study using this method, a news release was also published in 
the newsletter of a national breast cancer organization as 
40 
well as a local newspaper explaining the study and asking for 
volunteers. The same procedure was followed for these women. 
The criteria were then changed to include women whose mothers 
were living with breast cancer without knowing the stage of 
the mothers, disease. Women were excluded from the study if 
their mothers had died from breast cancer. 
Instruments 
All subjects were given a written information sheet 
explaining the study and were asked to complete the following: 
(1) an information sheet and consent form (Appendix B), 
(2) a demographic information sheet and questionnaire 
(Appendix C) requesting information such as address, age, 
education and occupation. In addition, the women were 
asked questions about (a) awareness of risk to self for 
breast cancer, (b) health behaviors practiced and (c) 
information concerning the family members of each of the 
subjects. 
(3) All women completed the Symptom Check List-90-R (SCL-90-R) 
(Appendix D) both before and after the class as well as 
in the final questionnaire packet. 
(4) The women were asked to complete a pretest (Appendix E) 
consisting of 25 true/false questions. 
(5) And a posttest (Appendix F), was given at the end of the 
second class, which was identical to the pretest. 
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(6) Six to twelve months after agreeing to participate with 
this study, all women were mailed a final questionnaire 
(Appendix G) which asked about awareness of risk to self 
for breast cancer, health behaviors practiced, physician 
visits, and status of other family member's health, as 
well as the same posttest and the SCL-90-R. 
The Symptom Check List-90-Revised (SCL-90-R) is a 90 item 
self-report symptom inventory designed primarily to reflect 
the psychological symptom patterns of psychiatric and medical 
patients. The instrument measures somatization, obsessive-
compulsive symptoms, interpersonal sensitivity, depression, 
anxiety, phobic anxiety, psychoticism, paranoid ideation, 
hostility and global indices of psychopathology. Furthermore, 
the global indices provide an assessment of the (1) intensity 
of perceived distress, (2) the number of symptoms experienced 
and (3) a summary measure combining intensity and a number of 
symptoms. 
The Clinical Psychometrics Research Unit of Johns Hopkins 
University devised the SCL-90-R, which evolved from the 
Hopkins Symptom Checklist (HSCL). This instrument had many 
drawbacks and was found to be clinically inadequate, which led 
to a preliminary version of the SCL-90. Based on early 
clinical experiences and psychometric analyses, the test was 
modified and validated in the present R (revised) form 
(Derogatis, Rickels & Rock, 1976), 
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The SCL-90-R consists of 90 self-description items that 
are rated on a 5-point scale of distress ranging from 0 (not 
at all) to 4 (extremely). An important aspect of any clinical 
assessment procedure is the time set reference given to the 
person to make his/her response. The standard time frame for 
the SCL-90-R is "7 days including today". The major rationale 
for this selection concerns the fact that the most recent 7 
days in a person's time frame usually provides the most 
relevant information to one's clinical status ( Deragotis, 
1977). Under usual circumstances the SCL-90-R requires 15-30 
minutes to complete. The test manual recommends that the 
measure be administered by someone who provides a positive 
impression of the benefits of psychological assessment. 
The SCL-90-R is a measure of current, point-in-time, 
psychological symptom status. It is not a measure of 
personality, except indirectly, in that certain personality 
"types" and "disorders" may manifest a charateristic profile 
on the primary symptom dimensions (Deragotis, 1977). 
The SCL-90-R may be used in a single, one-time assessment 
of the person's clinical status, or it may be used repeatedly 
either to document trends through time, or in a pre-post 
evaluations. Test-retest reliabilities are very good with an 
inability to detect any significant "practice" effects. 
Table 4 gives reliability information for each of the 9 
symptom areas. 
Table 4. 
Symptom Check List-90-Revised 
Symptom Dimension Internal Consistency 
(coefficient ) a 
I. Somatization 
II. Obsessive-Compulsive 
III. Interpersonal Sensitivity 
IV. Depression 
V. Anxiety 
VI. Hostility 
VII. Phobic Anxiety 
VIII. Paranoid Ideation 
IX. Psychoticism 
.86 
.86 
.86 
.90 
.85 
.84 
.82 
.80 
.77 
"symptomatic volunteers" 
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Test-Retest 
(r-tt) b 
.86 
.85 
.83 
.82 
.80 
.78 
.90 
.86 
.84 
(a) N=219 
(b) N=94 heterogeneous psychiatric outpatients with one 
one week time elapse between tests. 
Taken from SCL-90-R manual. 
The SCL-90-R is designed to reflect psychological symptom 
status in a broad spectrum of individuals, ranging from non-
patient "normal" respondents, through medical patients of 
various types, to individuals with psychiatric disorders. 
This broad spectrum of patients includes: alcoholics, drug 
users, students, patients with cancer and heart disease, and 
those with sexual disorders. 
The SCL-90-R enjoys a fair amount of success within an 
oncology population. Craig and Abeloff (1974) used the test 
to demonstrate clinical levels of psychological distress among 
patients with cancer, and Abeloff and Derogatis (1977) used 
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the SCL-90-R to characterize a speci fie symptom picture of 
patients with breast cancer. Subsequently, Derogatis (1980) 
utilized the "90" to argue that women diagnosed with breast 
and gynecological cancers present a unique psychological 
picture. In addition, Derogatis, Abeloff and Melisaratos 
(1979) used the SCL-90-R in a study that demonstrated length 
of survival with metatastatic breast cancer was distinctly 
related to coping style, a conclusion that was also reported 
by Rogentine and colleagues (1979) using the SCL-90-R with 
patients with malignant melanoma. 
The SCL-90-R has been used successfully as a psychiatric 
screening measure among patients with cancer. Derogatis, 
Lobo, Folstein and Abeloff (1983) used the "90" in a series of 
consecutive admissions to the cancer center with patients who 
had been pre screened positive or negative for psychiatric 
disorders by the General Hospital Questionnaire. The "90" 
discriminated positively from negatively screened patients, 
and also distinguished between positively screened patients 
judged in need of psychiatric intervention versus those judged 
to be without such a need (Derogatis, 1985). 
The SCL-90-R was chosen for this study for several 
reasons: (1) it has a fairly respectable reliability record, 
(2) the SCL-90-R is one of very few instruments that has had 
a broad utilization in oncology, and (3) therefore it would be 
interesting to determine validity with family members of 
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patients with cancer, specifically breast cancer, and ( 4) 
under usual circumstances it requires approximately 15-20 
minutes to complete. 
The primary intent of the didactic course was to share 
very general information about breast cancer. (See Appendix H) 
The curriculum was developed by combining the most recent 
published information about breast cancer, including: several 
books, ACS pamphlets, and chapters from major textbooks. The 
primary focus was to highlight important general information, 
specifically, awareness of risk, etiology of the disease, 
present facts and dispel! myths, discuss risk factors and 
detail and encourage the practice of early detection methods. 
The course purposely did not include information about the 
treatment of breast cancer. 
Various methods were used in the presentation of material, 
for example, handouts, slides, a BSE video, along with the ACS 
model for identifying normal vs. abnormal breast lumps, actual 
mammograms demonstrating normal vs. abnormal findings, 
homework assignments and a relaxation tape. 
A panel of experts including two internationally known 
oncologists who specialize in breast cancer and two oncology 
nurse clinical specialists reviewed the didactic course 
material for content validity. 
A review of the literature as well as conversations with 
other researchers in the field of breast cancer were contacted 
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to identify instruments to test for breast cancer knowledge. 
The review revealed only one instrument, The Breast Cancer 
Knowledge Test developed by Mccance, Mooney, Smith and Field 
(1990). This measure was fairly limited because it only 
measured knowledge about screening and detection of breast 
cancer. Therefore, a measure was developed specifically to 
core late to the course material presented. Reliability of 
this questionnaire will be discussed in Chapter IV. 
Procedure 
Once the study and the concept of randomization were 
explained to the daughters and they agreed to participate, 
subjects were randomized to attend the classes or receive 
questionnaires in the mail and attend the classes at a later 
time. (Approximately forty-five women declined to participate 
in this study). The randomization procedure consisted of using 
a random numbers list, the odd numbers were to attend the 
classes and the even numbers to the wait-list control group. 
If a woman received an odd number, the next step was to find 
a class time that suited multiple schedules. Depending on the 
women's schedule she would be assigned to the most convenient 
class of her choice. If a woman received an even number, she 
became part of the control group. It was then explained that 
she would be receiving a total of three packets of 
questionnaires in the mail. The first would be mailed within 
several days after the telephone conversation. The first and 
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second packets consisted of an information sheet/ consent 
form, a demographic sheet and questionnaire, the SCL-90-R, and 
the pretest. The women were asked to complete the forms as 
soon as possible and to return them in the stamped addressed 
envelope that had been supplied. It was explained that a 
second packet, similar to the first, would be mailed within 
one month of the completion of the first packet. A third 
packet would be mailed to them in approximately six months 
following the return of the second packet. For those women in 
the wait-list group, the final packet included a place for 
them to mark if they would like to attend the classes or 
receive information by mail. 
The classes were held at a large urban medical center in 
classrooms that were equipped with slide projector and VCR. 
The pilot study and the actual didactic courses were given by 
a master's-prepared Oncology Nurse. (This author interviewed 
several Oncology nurses and selection was based on level of 
experience, maturity and the nurse's ability to be flexible 
given the scheduling requirements of this study). Upon 
arrival at the medical center the volunteers were given the 
information/ consent form, demographic sheet, SCL-90-R, 
questionnaires and pretest, which took approximately twenty 
minutes to complete. 
After the women completed the initial questionnaires, the 
nurse gave an introduction to the classes and the handout, 
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(see Appendix I), followed by an eight minute relaxation tape 
that was played in order to help the women "wind down" from 
the hassles of their day. This was followed by the start of 
the formal part of the class. The first class ran 
approximately 1 hour and 45 minutes. The information that was 
given in the course included: 
- Benign versus malignant tumors, 
- Incidence of breast cancer, 
- Risk factors and family history, 
- Explanation of homework assignment, (between the 1st and 
2nd class the women completed a family Genogram focusing 
on Breast Cancer in their family). (See Appendix J). 
- Methods for early detection of breast cancer including: 
- Yearly Physician Examination, 
- Mammography (examples of normal and abnormal 
mammograms are presented). 
- Monthly Breast Self-Examination 
The course content for the second class included: 
- Review and questions from last week, 
- Relaxation tape was again played, 
- Discussion of other risk factors: hormone factors, 
life-style factors and fibrocystic changes, 
- Review of early detection methods, 
- View ACS video on Breast Self-Examination, 
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- Discuss homework assignment (their genogram), 
- Closing comments and completion of posttest. 
The second class took approximately 1 hour and 40 minutes. 
(See Appendix H for course outline and specific information 
that was presented). 
The schedule of the five classes held is as follows: 
First group: August 21 and 28, 1991, eight women were 
scheduled to attend, five women attended both classes. Two 
women completed only the first class, and one woman was a 
"no show", meaning she failed to call and cancel. The two 
women who did not attend were telephoned the next day and it 
was learned that one woman's babysitter was unable to come and 
the other woman was unable to return from vacation at the 
scheduled time. 
The second group of classes were held on September 14th 
and 21st. Seven women were scheduled to attend, four attended 
both classes, two of the women (they were sisters) called the 
morning of the first class to cancel; and one woman was a "no 
show". This investigator was unable to reach the "no show" 
woman for follow-up. 
The third group of classes was held on October 30 and 
November 6, 1991. Six women were scheduled to attend, four 
women attended the first class, one woman was a "no show" and 
one woman was unable to attend the second class. The woman 
unable to attend the second class was called for follow-up 
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purposes. She explained she had babysitting difficulties and 
possibly would be interested in attending the next group of 
classes. The investigator was unable to reach the "no show" 
for follow-up. 
The fourth group of classes were held on December 7 and 
December 14, 1991. Twelve women were scheduled to attend, ten 
women attended both classes, with one calling to cancel and 
one "no show". 
The fifth group of classes were held on March 24 and March 
31, 1992. Ten women were scheduled to attend, seven women 
attended both classes, two women unable to attend the second 
class and one "no show". 
In summary, forty-three women committed to attend the 
classes. Twenty-nine women attended both classes, five women 
attended one class, three women canceled and six women did not 
show for the classes. Twenty-five women have completed the 
final questionnarie, with four outstanding as of Nov. 9, 1992. 
In the control group (those in the wait-list group), 
thirty-one women agreed to the study, with one woman dropping 
out after receiving the pretest packet. All women in the 
control group (N=30) have completed the six or twelve month 
questionnaires. 
Analysis of Data 
Demographic information and answers to some of the pre 
and posttest questions were analyzed by calculating 
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frequencies (means, standard deviations, ranges). 
A repeated measures (or time series) analysis was 
performed to test the first three hypotheses: 
( 1) There will be no difference in knowledge scores about 
breast cancer between the experimental group and the control 
group over time (pretest, posttest and 6-12 month follow-up). 
(2) There will be no difference in awareness of risk to self 
for breast cancer between the experimental group and the 
control group over time (pretest, post test and 6-12 month 
follow-up). 
(3) There will be no difference in anxiety, depression and 
somatization scores between the experimental group and the 
control group over time (pretest, posttest and 6-12 month 
follow-up). 
A correlational analysis (chi square) was performed for 
hypothesis #4: there is no difference in heal th behaviors 
practiced between the experimental and the control group. 
CHAPTER IV 
RESULTS 
This study addressed the daughters' cognitions and 
behaviors relating to a maternal history of breast cancer as 
an outgrowth of several null hypotheses: 
( 1) There is no difference in knowledge about breast 
cancer between the experimental group and the control group 
immediately after attending breast cancer classes and at a 
6-12 month follow-up. 
(2) There is no difference in awareness of risk to self 
for breast cancer between the experimental and the control 
group immediately after attending breast cancer classes and at 
a 6-12 month follow-up. 
( 3) There is no difference in anxiety, depression and 
somatization levels between the experimental and control group 
immediately after attending classes about breast cancer and at 
a 6-12 month follow-up. 
(4) There is no difference in health behaviors practiced 
between the experimental and the control group immediately 
after attending information classes about breast cancer and at 
a 6-12 month follow-up. 
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Seventy-four women initially agreed to participate in 
this study. The experimental group included forty-three 
women who were randomly assigned to attend two 2 hour 
classes on specific evenings of their choice. Of the forty-
three women, six women never arrived for the first class, 
three called to cancel, and five women were unable to attend 
the second class. Therefore, there are thirty-four 
evaluable cases for pretest information and twenty-nine 
evaluable cases for posttest information in the experimental 
group. (The post test was one week after the pretest). Of 
the twenty-nine, three women did not return the 6-12 month 
questionnaire. 
Thirty-one women were randomly assigned to the control 
group, one woman did not return the original pretest packet, 
therefore, there were thirty evaluable cases in the control 
group. All control group women returned the 6-12 month 
questionnaire. 
Demographic Information 
Table 5 describes demographic information for sixty-
four women who participated in this study and compares the 
various population characteristics of the two groups. 
Demographic information is described for thirty-four women 
in the experimental group, which includes the five women who 
attended the first class, but who were unable to attend the 
second class. 
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Table 5. 
Demographic Information for All Participants 
Age of Participants 
Mean 
Range 
Education (completed) 
High School 
College 
Post Graduate 
Daughter's Age at 
Time of Mother's Dx* 
Mean 
Range 
Standard Deviation 
Mother's Age at Dx* 
Mean 
Range 
Standard Deviation 
Number of Years Living 
Experimental 
N = 34 
30.3 years 
22-40 years 
8 (23) 
20 (59) 
_§_ ilJU 
34 100 
24.4 years 
2-40 years 
8.39 years 
53.0 years 
38-70 years 
7.64 years 
w/ Breast Cancer History 
Mean 
Range 
5.8 years 
6 months - 27 years 
Dx* denotes the word diagnosis 
Control 
N = 30 
31.2 years 
22-40 years 
3 (10) 
15 (52) 
11 .Llfil 
29 100 
27.0 years 
9-39 years 
6.41 years 
52.8 years 
42-75 years 
7.04 years 
4.2 years 
6 months- 28 years 
Table 5 compares the various population characteristics 
of the two groups. Overall the groups were very well balanced. 
The participants ranged in age from 22 years to 40 years with 
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a mean age of 30.7 years. There is a high educational level 
represented in both groups with a slightly higher post-
graduate level in the control group. 
The daughters' age at the time of their mothers' 
diagnosis of breast cancer ranged in age from 2 to 40 years 
with a mean age of 24.4 years for the experimental group and 
a mean of 27 years for the control group. 
General demographic information about the mothers of the 
participating daughters includes the following: the age of the 
participants' mothers at the time of their diagnosis of breast 
cancer ranged from 38-75 years with a mean of 53 years for the 
experimental group and 52.8 for the control group. 
The length of time that the mothers had been diagnosed 
with breast cancer ranged from 6 months to 28 years, with a 
mean of 5 years (standard deviation of 6.3 years). The groups 
were similar in this category. 
The stages of the mothers' breast cancer at the time of 
the study ranged from Stage I to Stage IV. Information about 
each mother's stage of disease was unobtainable. 
The following is a summary of the responses reported by 
the daughters in both the experimental and control group to 
the question "what was the type of primary treatment that your 
mother received for breast cancer?". 
(1) The daughters reported that 80 percent of their mothers 
had received a mastectomy as the primary type of treatment for 
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their breast cancer. 
(2) The daughters reported that 28 percent of their mothers 
had had breast reconstructive surgery. 
(3) In addition, the daughters reported that 38 percent of 
their mothers had received radiation therapy. 
(4) According to the daughters, 46 percent of their mothers 
had received chemotherapy and 32 percent had received hormone 
therapy. (The mothers' medical records were not available to 
check the accuracy of the daughters' reports). 
In the early phases of this dissertation, the attempt was 
made to only include women whose mother's had a Stage I or II 
breast cancer. This inclusion criteria created difficulty for 
accruing subjects, therefore inclusion criteria was changed to 
include all stages of breast cancer. Women were not eligible 
if their mothers had died of breast cancer. 
Between Time 2 and Time 3, two of the participant's 
mothers in the experimental group had died and one of the 
participant's mothers in the control group had died. 
The occupations of the women in the experimental group 
included a wide variety of professions with the most 
frequently reported being that of homemaker (3), attorney (3) 
teacher ( 2), students, ( 2) and marketing consultant ( 2). 
Other occupations reported included: accountant, sales, 
computer engineer, secretary and health care professions such 
as nurse, molecular biologist and pharmacy technician. 
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In the control group the most frequent occupations 
reported included: homemaker (9), teacher (3), office manager 
(3), and graduate student (2). Other occupations reported 
included: marketing consultant, chef, public relations, credit 
analyst, social worker/therapist, art historian and dance 
instructor. 
Analysis of First Null Hypothesis 
In order to test the first null hypothesis (there is no 
difference in knowledge about breast cancer between the 
experimental and the control group) the Breast Cancer 
Knowledge Questionnaire was evaluated. 
The questionnaire consisted of 25 true\false questions 
asking general information about breast cancer (see Appendix 
E). The questionnaire was evaluated for reliability using the 
Hoyt method, which yielded a reliability coefficient of 0.65. 
This method is based on using analysis of variance, treating 
persons and items as sources of variance. The sources of 
variance accounted for individuals taking the test over three 
separate time points. This is not the most favorable 
reliability score to obtain, however, it was not the intention 
of this study to develop an instrument for testing knowledge 
of breast cancer. However based on the results of this study, 
this would be a worthwhile area for further exploration. 
The knowledge scores were based on the number of correct 
responses to the Breast Cancer Knowledge Questionnaire. 
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Sixty-four women answered the pretest questionnaire with a 
mean of 18.4 correct answers (standard deviation= 2.0) with 
a range of correct answers from 14-24. 
Table 6 contains the mean scores and standard deviations 
of knowledge scores between the experimental and the control 
group over three time periods. In the experimental group the 
three time points included: (1) the pretest, which was given 
at the beginning of the first night of class, (2) the 
posttest, which was one week later at the end of the final 
class and (3) a follow-up time period ranging from five to 
twelve months after attending the classes. 
For the control group the three time points included: (1) 
the pretest, which was mailed to the participants after they 
agreed to participate in the study, (2) the posttest, which 
was mailed immediately after receiving the pretest packet and 
( 3) the final packet, which was mailed approximately 4-6 
months after receiving the posttest responses. 
The mean knowledge score for the experimental group was 
18. 20 (standard deviation of 2. 01) and the mean knowledge 
score for the control group was 18.73 (standard deviation of 
2.10). These scores represent very little difference between 
the two groups as measured at Time 1, which is the pretest 
measurement. 
In the experimental group at Time 2, there was a mean 
knowledge score of 23.76 (standard deviation of 1.27)~ In the 
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control group at Time 2, the mean knowledge score was 19.70 
(standard deviation of 1.96). 
At Time 3 the mean score was 22.26 (standard deviation of 
2.14) in knowledge scores in the experimental group and the 
mean score was 19.79 (standard deviation of 2.48) in knowledge 
scores in the control group. 
Table 6. 
Breast Cancer Knowledge Questionnaire Scores 
Knowledge Score (Time 1) 
Cell Means 
Standard Deviation 
Knowledge Score (Time 2) 
Cell Means 
Standard Deviation 
Knowledge Score (Time 3) 
Cell Means 
Standard Deviation 
Experimental 
N = 34 
18.20 
2.01 
N = 29 
23.76 
1. 27 
N = 26 
22.27 
2.14 
Control 
N = 30 
18.73 
2.10 
N = 30 
19.70 
1. 96 
N = 29 
19.79 
2.48 
Figure 1 contains a plot of the interaction of mean 
scores between the experimental and the control group, which 
indicates a disordinal interaction. This plot indicates 
confounding inferences to main effects and significant 
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differences between the experimental and control group means 
for both group and knowledge. Because of differences between 
the experimental and control group noted in Figure 1, a 
repeated measure analysis of variance and the Tukey's HSD post 
hoc test of significance was applied for each time period (See 
Table 7). 
Figure 1. 
Plot of the Knowledge Scores Between the Experimental and 
Control Groups 
Mean Scores 
23.7 
22.5 
20.0 
Time 
+ + 
+ + 
~+~~~~~~~~~~~+~~~~~~~~~~~~+ 
1 2 
(pretest) (post test) 
3 
(follow-up) 
E = Experimental Group C = Control Group 
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A repeated measure analysis of variance was used to 
analyze the knowledge scores for the experimental group and 
the control group at the three time points. As can be seen in 
Table 7 both groups of women appear to have approximately the 
same knowledge score at pretest measurement (Time 1) with the 
control group being slightly higher. 
There is an extremely robust statistically significant 
difference (p= 0.01) between Time 1 and Time 2, suggesting 
that there was a positive impact from the intervention with 
significant information gained by the women who attended the 
classes. 
At Time 3 there is again a statistically significant 
difference in knowledge scores (p= 0.01) between the two 
groups, suggesting that the experimental group retained some 
of the information gained from the classes. 
In summary, at Time 1, the first null hypothesis, there 
will be no difference in knowledge about breast cancer between 
the experimental group and the control group fails to be 
rejected. 
At Times 2 and 3, the first null hypothesis, there will 
be no difference in knowledge about breast cancer between the 
experimental and the control group is rejected, with the 
experimental group showing a statistically significant higher 
knowledge score. 
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Table 7. 
Repeated Measure Analysis of Variance for Knowledge Scores 
with Post Hoc Test of Significance 
Time 1 
Mean + S.D. 
Source 
Group 
Time 2 
Mean+ 
Source 
Group 
Tu key 
Time 3 
Mean+ 
Source 
Group 
S.D. 
HSD 
S.D. 
Tu key HSD 
D.F. 
1 
D.F. 
1 
D.F. 
1 
Experimental 
(N = 34) 
18.20 (2.01) 
Mean Square 
4.43 
Experimental 
(N = 29) 
23.76 (1.27) 
Mean Square 
242.89 
Experimental 
(N = 26) 
22.27 (2.14) 
Mean Square 
84.05 
F 
(p 
F 
F Value 
1. 05 
Value 
87.84 
= 0.01) 
Value 
15.47 
(p = 0.01) 
Control 
(N = 30) 
18.73 (2.10) 
Probability 
0.30 
Control 
(N = 30) 
19.70 ( 1. 96) 
Probabilitv 
o.ooo 
Control 
(N = 29) 
19.79 (2.48) 
Probability 
0.0002 
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Analysis of Second Null Hypothesis 
In order to evaluate the second null hypothesis (there is 
no difference in awareness of risk to self for breast cancer 
between the experimental and control group) the pretest 
question "what percentage best describes YOUR chance of 
developing breast cancer some day?" was examined with repeated 
measure analysis of varience as well as a Tukey HSD post hoc 
test for significance. (See Table 8). 
As was discussed in Chapter One, women with a maternal 
history of breast cancer have approximately a 20 percent 
chance of developing breast cancer. 
As can be seen in Table 8, at Time 1 both groups 
significantly overestimated their chances of developing breast 
cancer someday. At Time 1, the experimental group reported a 
47 percent risk (mean score) with a range of 10 to 100 percent 
risk to self for developing breast cancer someday. At Time 1, 
the control group reported a 57 percent risk (mean score) with 
a range of 20 to 100 percent risk to self for developing 
breast cancer someday. 
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Table 8. 
Repeated Measure Analysis of Variance for Percent of Risk 
with Tukey HSD Test of Significance 
Time 1 
Mean + S.D. 
Range 
Source 
Group 
Time 2 
Mean+ 
Range 
Source 
Group 
Tu key 
Time 3 
Mean+ 
Range 
Source 
Group 
S.D. 
HSD 
S.D. 
Tu key HSD 
D.F. 
1 
D.F. 
1 
D.F. 
1 
Experimental 
(N = 32) 
0.47 (0.24) 
0.10 - 100% 
Mean Square 
0.18 
Experimental 
(N = 29) 
0.21 (0.07) 
0 .10 - 0.50 
Mean Square 
0.60 
Experimental 
(N = 23) 
0.23 (0.13) 
0 .10 - 0.55 
Mean Square 
0.83 
F Value 
3.06 
F Value 
19.98 
(p = 0.01) 
F Value 
27.72 
(p = 0.01) 
Control 
(N = 30) 
0.58 (0.25) 
0.20 - 100% 
Probability 
0.085 
Control 
(N = 30) 
0.41 (0.23) 
0.10 - 0.90 
Probability 
o.ooo 
Control 
(N = 29) 
0.48 (0.20) 
0.15 - 100% 
Probability 
o.ooo 
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There is a statistically significant difference in the 
perceived percent of risk (mean scores) between the two 
groups at Time 2 (p< 0.01). The experimental group reported a 
perceived 21 percent risk (an accurate percent of risk) and 
the control group reported a perceived 41 percent risk to 
self. This suggests that there was a positive effect from the 
breast cancer classes on the experimental group. 
At Time 3 there is also a statistically significant 
difference (p = 0.01) in percentage of risk reported between 
the experimental group and the control group between Time 2 
and Time 3. The experimental group reported a 23 percent risk 
(slightly higher than Time 2) and the control group reported 
a 48 percent risk (again a continued overestimate of risk). 
In summary, at Time 1, the second null hypothesis, there 
is no difference in awareness of risk to self for breast 
cancer between the experimental and the control group is not 
rejected. However, for Times 2 and 3, there is a difference 
between the experimental and control groups, therefore the 
hypothesis is rejected. 
Awareness of Perceived Risk to Average Woman 
To understand the participant's perception of the average 
woman's risk of developing breast cancer, the women were asked 
to respond to the following question: "What percent best 
describes the AVERAGE woman's chances of developing breast 
cancer someday"? The responses to this question were examined 
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by performing a repeated measure analysis of variance as well 
as a Tukey HSD test of significance. (See Table 9). 
As was discussed in Chapter One, the average woman's 
lifetime risk for developing breast cancer is approximately 10 
percent. As seen in Table 9, there was a statistically 
significant difference in the perceived risk for breast cancer 
in the average woman between the two groups at all three time 
points. At Time 1, the experimental group reported 20 percent 
(mean score) as the average woman's risk for developing breast 
cancer, with the range being from 5 to 90 percent. 
The control group at Time 1 perceived the average woman's 
risk to be 32 percent (mean score), with a range from 10 to 90 
percent. Both groups overestimated the risk, however, the 
control group perceived a greater risk than the experimental 
group. The difference between the groups is statistically 
significant at the p< 0.01 level. 
At Time 2, the experimental group reported the average 
woman's risk to be 10 percent (mean score), an accurate 
answer, suggesting a positive effect from the breast cancer 
classes. The control group reported a mean score of a 21 
percent risk for the average woman developing breast cancer, 
a decrease from Time 1, although still an overestimate. There 
is a highly statistically significant difference (p=0.01) in 
perceived risk for the average woman developing breast cancer 
between the two groups. 
67 
Table 9. 
Repeated Measure Analysis of Variance for Average Woman's 
Percent of Risk with Tukey HSD Test of Significance 
Time 1 Experimental Control 
(N = 33) (N = 30) 
Mean+ S.D. 0.20 (0.16) 0.32 (0.20) 
Source D.F. Mean Sguare F Value Probability 
Group 1 0.24 7.39 0.0085 
Tu key HSD (p = 0.01) 
Time 2 Experimental Control 
(N = 28) (N = 30) 
Mean+ S.D. 0 .10 ( 0. 02) 0.21 (0.14) 
Source D.F. Mean Sguare F Value Probability 
Group 1 0 .16 14.31 0.004 
Tukev HSD (p = 0.01) 
Time 3 Experimental Control 
( N = 25) (N = 29) 
Mean+ S.D. 0.11 (0.03) 0.29 (0.17) 
Source D.F. Mean Sguare F Value Probability 
Group 1 0.45 27.87 0.0000 
Tu key HSD (p = 0.01) 
At Time 3, the mean score for the experimental group was 
11 percent, an accurate response for the average woman's risk 
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of developing breast cancer. Whereas the mean score for the 
control group was 29 percent, a continued overestimate of the 
average woman's risk. The difference between the two groups 
remains statistically significant at the p<0.01 level. 
Analysis of Third Null Hypothesis 
Anxietv Results 
In order to evaluate the third null hypothesis (there is 
no difference in anxiety levels between the experimental group 
and the control group after attending breast cancer classes 
the Symptom Check-List Revised (SCL-90-R) was evaluated. 
Raw scores were entered into the computerized program 
which generated T scores for each of the nine subscales and 
three global indices of distress. The analysis was primarily 
looking at three psychological variables: anxiety, depression 
and somatization, therefore the T scores for these three 
variables were evaluated by performing frequency statistics as 
well as a repeated measure analysis of variance over three 
time periods to examine for possible differences between the 
experimental and control groups. 
Table 10 contains the cell means and standard deviations 
for anxiety scores in the experimental and control group over 
3 time periods. At Time 1, the anxiety mean score for the 
experimental group was 50.64 (9.90) and the anxiety mean score 
for the control group was 51.82 (10.85). 
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Table 10. 
Means and Standard Deviations for SCL-90-R Anxiety Scores 
Between Experimental and Control Groups Over Time 
Time 1 
Mean 
Standard Deviation 
Range of Scores 
Time 2 
Mean 
Standard Deviation 
Range of Scores 
Time 3 
Mean 
Standard Deviation 
Range of Scores 
Experimental 
(N = 25) 
50.64 
9.90 
37 - 72 
Experimental 
(N = 25) 
48.80 
9.33 
37 - 70 
Experimental 
(N = 25) 
48.72 
9.99 
37 - 68 
At Time 2' the anxiety mean score for 
group was 48.8. (9.33) and the mean score 
group was 52.57 ( 9. 52). 
At Time 3' the anxiety mean score for 
group was 48.72 (9.99) and the mean score 
group was 51. 71 (10.44). 
the 
for 
the 
for 
Control 
(N = 28) 
51. 82 
10.85 
37 - 77 
Control 
(N = 28) 
52.57 
9.52 
37 - 71 
Control 
(N = 28) 
51. 71 
10.44 
37 - 72 
experimental 
the control 
experimental 
the control 
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Figures 2, 3 and 4 demonstate the decrease in anxiety, 
depression and somatization scores from Time 1 through Time 3. 
Although not statistically significant, it may be assumed that 
the breast cancer classes contributed to this decrease. Of 
interest is the decrease in anxiety scores in the experimental 
group was maintained from Time 2 to Time 3. 
Figure 2. 
Plot of SCL-90-R Anxiety Scores Between Experimental and 
Control Group Over Three Time Points 
Mean Scores + •••••••••••••••• + ••.••••••••••••• + •• 
52.50 + + 
+ + 
50.75 + + 
49.00 + + 
.+ ..••.•••••••••• + •••••••••••••••••• + •• 
1 2 3 
Time Points 
Although there appears to be a decrease in the anxiety 
scores for the experimental group from Time 1 to Time 2 
which holds for Time 3, and the control group scores remain 
about the same over the 3 time points, however, there was no 
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statistically significant differences between the two groups. 
Therefore the null hypothesis can not be rejected (there are 
no differences in anxiety levels between the two groups before 
or after attendance at breast cancer classes). (See Table 11). 
Table 11. 
Results of Repeated Measure Analysis of Variance for Anxiety 
Scores Between Experimental and Control Group Over Tlme 
Source D.F. Mean E Probability 
Square 
Mean 1 407578.27 1775.81 0.000 
Group 1 278.05 1. 21 0.276 
ANX 1 2 13.60 0.37 0.690 
AG 2 23.33 0.64 0.528 
(Interaction) 
Depression Results 
In addition to assessing anxiety scores, depression 
scores were also evaluated by the SCL-90-R computerized 
scoring system. A repeated measure analysis of variance was 
used to evaluate differences in depression scores between the 
experimental and control groups over three different time 
points. The results are contained in Table 12. 
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Table 12. 
Means and Standard Deviations for SCL-90-R Depression 
Scores Between the Experimental and Control Group Over Time 
Time 1 
Mean 
Standard Deviation 
Range of Scores 
Time 2 
Mean 
Standard Deviation 
Range of Scores 
Time 3 
Mean 
Standard Deviation 
Range of Scores 
Experimental 
(N = 25) 
54.00 
9.33 
34 - 75 
Experimental 
(N = 25) 
49.92 
10.46 
34 - 81 
Experimental 
(N = 25) 
51.76 
10.98 
34 - 73 
Control 
(N = 28) 
53.53 
7.81 
34 - 69 
Control 
(N = 28) 
53.78 
7.65 
34 - 69 
Control 
(N = 28) 
52.85 
7.69 
34 - 70 
As seen in Table 12, at Time 1, the experimental group 
had a mean depression score of 54. 00 ( 9. 33) with scores 
ranging from 34 to 75. The mean score for depression in the 
control group 53.53 (7.81) with scores ranging from 34 to 69. 
At Time 2, the mean scores for depression for the 
experimental group were 49.92 (10.46). The mean scores for 
depression for the control group were 53.78 (7.65). 
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At Time 3, the mean scores for depression for the 
experimental group were 51.76 (10.98). The control group mean 
scores for depression were 52.85 (7.69). 
Figure 3. 
Plot of SCL-90-R Depression Scores Between Experimental 
and Control Group Over Three Time Points 
Mean Scores 
.+ .•.•••.••...•••. + ••••••••••••••• + •• 
54.25 + + 
52.50 + + 
50.75 + + 
•• + ••••••••••••••• + ••••••••••••••• + •• 
1 2 3 
Time Points 
As can be seen in Figure 3, both groups have somewhat 
higher depression scores than anxiety scores at Time 1. There 
is a decrease in scores between Time 1 and Time 2, however, 
the decrease does not appear to have lasting effects. At Time 
3 both groups are still lower than at Time 1, but are 
beginning to merge. 
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Table 13 contains the results of the repeated measure 
analysis of variance for depression scores between the two 
groups over three time points. Although there is a decrease 
in the depression scores for the experimental group between 
Time 1 and Time 2, there is no statistical difference seen. 
Table 13. 
Repeated Measure Analysis of Variance for Depression Scores 
for Experimental and Control Groups Over Time 
Source D.F. Mean 
.E Probability 
Square 
Mean 1 439224.19 2263.62 0.0000 
Group 1 89.09 0.46 0.50 
Depression 2 52.87 2.12 0.12 
DG 2 63.51 2.54 0.08 
(Interaction) 
As shown in Table 13, there are no statistically 
significant differences in depression scores as measured on 
the SCL 90-R between the experimental and the control group 
over three time points. Therefore the third null hypothesis 
(there is no difference in depression scores between the two 
groups) cannot be rejected. 
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Table 14. 
Means and Standard Deviations for SCL 90-R Somatization 
Scores Between the Experimental and Control Group Over Time 
Time 1 
Mean 
Standard Deviation 
Range of Scores 
Time 2 
Mean 
Standard Deviation 
Range of Scores 
Time 3 
Mean 
Standard Deviation 
Range of Scores 
Somatization Results 
Experimental 
(N = 25) 
50.64 
8.05 
35 - 66 
Experimental 
(N = 25) 
47.44 
8.74 
35 - 66 
Experimental 
(N = 25) 
49.72 
10.19 
35 - 72 
Control 
(N = 28) 
51.75 
8.98 
35 - 68 
Control 
(N = 28) 
51. 35 
9.03 
35 - 65 
Control 
(N = 28) 
52.10 
8.00 
35 - 62 
Somatization is the third psychological variable to be 
evaluated. The T scores from the SCL-90-R computerized 
scoring system were analyzed by computing frequencies which 
resulted in the following findings that are contained in the 
above table. At Time 1, the mean score for somatization for 
the experimental group was 50.64 (8.05) and the mean score for 
somatization for the control group was 51.75 (8.98). 
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At Time 2, the mean score for somatization for the 
experimental group was 47.44 (8.74) and the mean score for 
somatization for the control group was 51.35 (9.03). 
At Time 3, the mean score for somatization for the 
experimental group was 49.72 (10.19) and the mean score for 
somatization was 52.10 (8.00). Figure 4. contains the results. 
Figure 4. 
Plot of SCL-90-R Somatization Scores Between Experimental 
and Control Group Over Three Time Points 
Mean Scores 
.+ •.•.••.•.•.•••.• + •••••.•••••••••• + .• 
52.00 + + 
50.00 + + 
48.00 + + 
.+ .••••••.•••.•••• + ••••••••••••••••• +. 
1 2 3 
Time Points 
Table 15 contains the results for the repeated measure 
analysis of variance for somatization scores between the two 
groups over three time periods. Although there was a decrease 
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in somatization scores in the experimental group from Time 1 
to Time 2, there was no statistical difference seen between 
the two groups. Therefore, the third null hypothesis (there 
is no difference in somatization scores between the two groups 
was accepted. 
Table 15. 
Repeated Measure Analysis of Variance for Somatization 
Scores for Experimental and Control Groups Over Time 
Source D.F. Mean Square F Value Probability 
Mean 1 404228.68 2378.48 0.000 
Group 1 242.01 1.42 0.23 
Soma ti-
zation 2 49.32 1. 51 0.22 
(Interaction) 
SG 2 26.08 0.81 0.45 
Analysis of Fourth Null Hypothesis 
There will be no difference in health behaviors practiced 
between the experimental and control group. This hypothesis 
was evaluated by analyzing three separate health behaviors: 
Pap test screening, obtaining Mammograms and evaluating the 
frequency of breast self-examination. 
Pap Test Screening 
At Time 1 the pretest question, "Have you ever had a Pap 
test?" was asked, and "If yes, when was your last one?" This 
question was evaluated by looking at frequencies. All 64 women 
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answered "Yes" to this question with a mean time of 9 months 
(s.d. of 8.5 months) since their last Pap test. 
At Time 3, in the final questionnaire the women were 
asked, "Since the time you agreed to participate in this 
study, have you been to a physician for a Pap test?" This 
question was evaluated by looking at frequencies. In the 
experimental group, 8 women reported NO (30 percent) and 18 
replied YES, therefore, 70 percent of this group (N=26) had 
received another Pap test. 
In the control group, 6 women responded NO (20 percent) 
and 24 women responded YES, therefore 80 percent of this group 
(N=30) had received another Pap test. 
A Pearson chi-square correlation was performed to test 
for differences between the experimental and control group in 
obtaining a Pap test. The results yeilded a chisquare value of 
0.862 (p = 0.35) showing no statistically significant 
differences between the two groups. 
Mammography Utilization 
To evaluate Mammography as a practiced heal th behavior, at 
Time 1 the women were asked, "Have you ever had a Mammogram?". 
A total of 34 women in the experimental group responded; 20 
(59 percent) reported YES, while 14 (41 percent) replied NO. 
A total of 28 women in the control group responded at Time 1; 
14 reported YES (50 percent) and 14 reported NO (50 percent). 
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According to American Cancer Society guide! ines, the 
cost/benefit ratio for obtaining mammograms for women under 
age 30, (even for those at higher risk) is not effective. 
Therefore this question was further explored by performing a 
Pearson chi-square correlation based on participants 30 years 
of age and older. Table 16 contains the results for women 30 
years of age or older in the experimental group at Time 1. 
Table 16. 
Differences in Use of Mammography Between the Experimental and 
Control Group at Time 1 for Women 30 Years of Age and Older 
Mammograms Experimental Control 
YES 13 (77 percent) 12 (75 percent) 
NO _i (23 percent) ! (25 percent) 
Total 17 (100 percent) 16 (100 percent) 
Pearson Chi-square = 0.010 (p = 0.92) 
Of the women in the experimental group who were 30 years 
of age or older, 13 of 1 7 ( 7 7 percent) had obtained a 
mammogram, while 4 out of 17 (23 percent) had not ever had a 
mammogram. In the control group 12 out of 16 (75 percent) had 
obtained a mammogram, while 4 out of 16 (25 percent) had not 
ever had a mammogram. These results yielded a chi-square of 
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Table 17. 
Differences in Use of Mammography Between the Experimental and 
Control Group at Time 3 for Women 30 Years of Age and Older 
Mammograms 
YES 
NO 
Experimental 
7 (58 percent) 
_Q_ -1..1...2. percent) 
12 (100 percent) 
Pearson Chi-square = 0.19 (p = 0.66) 
Control 
8 (50 percent) 
_1i _J_QQ percent) 
16 (100 percent) 
In the experimental group, a total of 26 women responded 
to the question of obtaining a mammogram since participating 
in this study. Twelve of the 26 women were 30 years of age or 
older, seven had obtained a mammogram and five women had not. 
Of the 30 women in the control group, 16 were 30 years of 
age or older, eight had obtained a mammogram and eight had 
not. 
A Pearson chi-square correlation was performed to look 
for differences between the experimental and control groups 
from Time 1 to Time 3. (See Table 18). 
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Table 18. 
Differences in Mammograms Obtained in the Experimental Group 
Between Time 1 and Time 3 
Experimental Group 
T Time 1 
I NO YES Total 
M NO 8 11 19 
E YES 2 5 7 
3 Total 10 16 26 
Pearson chi-square = 0.40 (p = 0.53) 
In the experimental group, eight women reported that 
they had never had a mammogram at either Time 1 or Time 3. 
Two women who had not had a mammogram at Time 1, did obtain a 
mammogram between Time 1 and Time 3. Eleven women reported 
YES to having had a mammogram at Time 1. Five women reported 
having had a mammogram at Time 1 and also obtained a mammogram 
between Time 1 and Time 3. 
Table 19. 
Differences in Mammograms Obtained in the Control Group 
Between Time 1 and Time 3 
Control Group 
Time 1 
83 
NO YES Total 
T NO 10 6 16 
I 
M YES 3 8 11 
E 
Total 13 14 27 
3 
Pearson chi-square = 3.24 (p = 0.07) 
In the control group, 10 women had not obtained a 
mammogram at Time 1 nor at Time 3. Three women had not 
obtained a mammogram at Time 1, however they had obtained a 
mammogram by Time 3. Six women had obtained a mammogram at 
Time 1, but did not obtain a mammogram between Time 1 and Time 
3. Eight women had obtained a mammogram at Time 1 and also 
obtained a mammogram between Time 1 and Time 3. 
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Breast Self-Examination 
To evaluate breast self-examination as the third health 
behavior practiced, frequencies were calculated for responses 
to the question, "Have you ever done breast self-examination"? 
At Time 1, a total of 31 out of 34 women (91 percent) in the 
experimental group replied YES, and 3 women ( 9 percent) 
replied NO. 
At Time 1, 27 out of 30 women in the control group 
replied YES ( 90 percent) and 3 ( 10 percent) replied NO. A 
Pearson chi-square value of 0.026 (p = 0.87) was found, 
therefore there is no statistically significant difference in 
performing breast self-examination between the experimental 
and control group at Time 1. 
At Time 1 the women were asked, "when was the last time 
you examined your breast"? In order to evaluate this question 
the responses were calculated in months or portions of a month 
and frequencies were performed. In the experimental group, 31 
women responded resulting in a mean score of 2.5 months, 
(s.d. = 6.32) ranging in time from one week to 36 months. 
In the control group, 24 women responded to the question 
resulting in a mean score of 3.5 months (s.d.= 6.02) ranging 
in time from 1 month to 24 months. 
Table 20 contains the results of the frequency of BSE 
between the experimental and control group at Time 3. 
Table 20. 
Freguencv of Breast Self-Examination Between 
the Experimental and Control Group at Time 3 
Frequency Experimental 
N ~ 
More than once/month 3 11 
Monthly 13 50 
Every other month 6 23 
Four times a year 1 04 
Twice a year 0 0 
Once a year 1 04 
Not at all 2 08 
Total 26 100 
Pearson chi-square value = 4.50 (p = 0.60) 
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Control 
N ~ 
4 13 
13 43 
3 10 
2 07 
2 07 
1 03 
_5_ 
-1.L 
30 100 
As seen in the above table, 13 women (50 percent) in the 
experimental group and 13 women (43 percent) in the control 
group practice BSE on a monthly basis, which is the 
recommendation from the American Cancer Society. Six women 
(23 percent) in the experimental group and three women (10 
percent) in the control group practice BSE every other month, 
also likely to be an effective frequency. Three women (11 
percent) in the experimental group and 4 women (13 percent) in 
the control group practice BSE more than once a month, which 
is more than is necessary. These numbers account for 84 
percent of the women in the experimental group and 66 percent 
of the women in the control group are performing BSE within 
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the ACS guidelines for frequency. Therefore the majority of 
these "high risk women" are already practicing BSE at the 
correct frequency. Only four women ( 16 percent) in the 
experimental group and 10 women (34 percent) in the control 
group are not performing BSE frequently enough and could 
therefore improve in the practice of this health behavior. 
To evaluate for possible changes in the practice of BSE 
between Time 1 and Time 3, responses were recategorized and 
then reexamined. Forty-seven women in both the experimental 
and control groups reported their frequency of BSE at both 
Time 1 and Time 3. 
Overall, 27 women reported no change in the frequency of 
BSE practice. Of these 27 women, 21 continued to practice BSE 
monthly. Thirteen women increased their frequency of BSE 
practice, while five women decreased their frequency of BSE. 
In the experimental group thirteen women did not change 
their frequency of BSE, 11 continued a monthly practice, one 
continued to practice more than once a month and one continued 
an every other month schedule. Six women increased their BSE 
and four women decreased their frequency of BSE. 
In the control group, 24 women were reevaluated for 
changes in frequency of BSE from Time 1 to Time 3. Fourteen 
women did not change the frequency of their BSE, seven women 
increased their freqency and three women decreased their 
frequency of BSE. 
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Overall, because the majority of women were correctly 
practicing an appropriate frequency of BSE, there were too few 
numbers to demonstrate any statistically significant 
differences between the two groups. 
Summary of the Results 
The experimental group included 43 women who were 
randomized to attend two 2 hour classes. There are 34 
evaluable cases for pretest information. Due to scheduling 
problems there are 29 evaluable cases for posttest evaluation. 
There are a total of 30 evaluable cases in the control group. 
The two groups appear to be fairly homogeneous in demographic 
background. 
The following is a summary of the results by hypotheses. 
(1) Based on repeated measure analysis of varience using a 
Tu key HSD test of significance, at Time 1, the first null 
hypothesis (there will be no difference in knowledge about 
breast cancer between the experimental and control group) is 
not rejected. At Times 2 and 3, the first null hypothesis is 
rejected due to a statistically significant difference 
(p<0.01) between the groups in knowledge about breast cancer. 
(2) Based on repeated measure analysis of varience as well 
as the Tukey HSD post hoc test of significance, the second 
null hypothesis (there will be no difference in awareness of 
risk to self for breast cancer between the experimental and 
control group) is not rejected at Time 1. However, there is a 
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statistically significant difference in awareness of risk to 
self between the 2 groups between Time 1 and Time 2, which 
holds up at Time 3 at the p < 0. 01 level. Therefore, the 
second null hypothesis is rejected for Times 2 and 3. 
Three psychological variables: anxiety, depression and 
somatization as measured on the SCL-90-R were evaluated using 
a repeated measure analysis of varience in order to test the 
third null hypothesis (there will be no differences in 
anxiety, depression and somatization scores between the 
experimental and control groups immediately after the classes 
and at follow-up). 
( 3) Al though not statistically significant, there is a 
decrease in anxiety scores for women in the experimental group 
between Time 1 to Time 2, which is maintained at follow-up 
(Time 3). The scores for the women in the control group 
remain about the same over the three time points. In summary, 
there are no statistically significant differences between the 
two groups in the three psychological variables, therefore the 
third null hypothesis can not be rejected. 
(4) Although not statistically significant, there is a 
decrease in depression scores for the experimental group 
between Time 1 to Time 2, while the control group scores 
remain about the same over the three time points. Therefore, 
the third null hypothesis can not be rejected. 
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( 5) Al though not statistically significant, there is a 
decrease in somatization scores in the experimental group 
between Time 1 to Time 2, while the control group remains 
approximately the same. Therefore the third null hypothesis 
can not be rejected. 
The fourth hypothesis (there will be no difference in 
health behaviors practiced between the experimental and 
control groups immediately after the classes and at follow-
up), was evaluated by analyzing frequencies of three separate 
health behaviors: Pap test screenings, obtained mammograms and 
frequency of breast self-examination. 
(6) At Time 1 all of the women in both the experimental 
and control group (N=64) had received a Pap test. Between 
Time 1 and Time 3, 70 percent of the experimental group and 80 
percent of the control group had received another Pap test. A 
Pearson chi-square correlation was performed to test for 
differences between the two groups. No statistically 
significant differences were found between the two groups, 
therefore the null hypothesis (there will be no difference in 
Pap test screening between the experimental and control group} 
can not be rejected. 
(7) Obtained mammograms is the second health behavior to 
be evaluated. Evaluation of differences in mammograms 
obtained between Time 1 and Time 3 resulted in no 
statistically significant differences between the two groups. 
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Therefore the fourth null hypothesis (there is no difference 
in health behaviors practiced (obtained mammograms) between 
the experimental and control groups) can not be rejected. 
(8) Evaluation of breast self-examination practices showed 
that 84 percent of women in the experimental group and 66 
percent of women in the control group are performing BSE on a 
monthly or every other month basis, which is in accordance 
with American Cancer Society guidelines. Overall, because the 
majority of women were practicing BSE on an appropriate 
schedule, the numbers for those not practicing BSE correctly 
were too small to calculate for any statistically significant 
differences between Time 1 and Time 3 between the two groups. 
Therefore the fourth null hypothesis, there is no difference 
in health behaviors practiced (changes in frequency of BSE 
practice) between the experimental and control group can not 
be rejected. 
CHAPTER V 
SUMMARY, DISCUSSION AND CONCLUSIONS 
Summary 
Using the Heal th Belief Model (Rosenstock, 1990) as a 
theory base and recognizing the potential severity and 
chronici ty of breast cancer, it was appropriate to address 
several issues that effect the daughters of women with breast 
cancer. Specifically, the purpose of this randomized, 
controlled, intervention study was: 
(1) to better understand their knowledge about breast cancer, 
(2) to identify an awareness of their perceived risk for the 
disease, 
(3) to identify psychological factors that may or may not be 
affecting these women (i.e. anxiety, depression and 
somatization), 
(4) to identify early detection health behaviors practiced by 
this group before and after attending classes about breast 
cancer, 
(5) and to investigate the impact of a didactic group 
experience about breast cancer on women who potentially 
have a high risk of developing the disease. 
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Breast cancer is increasing in incidence with 182,000 new 
cases occuring in 1993 (ACS, Facts and Figures, 1993). The 
most important factors influencing a woman's likelihood of 
developing breast cancer include: advancing age, history of a 
previous breast cancer and a history of breast cancer in a 
mother or sister diagnosed prior to menopause (Stoll, 1991). 
The five year survival rate for localized breast cancer 
(Stage I) has risen from 78 percent in the 1940' s to 92 
percent today. The survival rate is directly related to the 
size of the breast lesion, therefore early detection of breast 
cancer remains a crucial key to increased cure rates and 
survival. 
There are three established methods of early detection 
for breast cancer: physical examination, mammography and 
breast self-examination. However there is a very low 
frequency of compliance with these three methods. 
Sixty-four women with a maternal history of breast cancer 
were randomly assigned to attend two breast cancer classes or 
be placed on a wait-list control group. The women were asked 
to complete demographic information, the Symptom Check-List-
90-Revised (SCL-9-R), a pretest, posttest and follow-up 
questionnaire. 
Limitations of the Study 
The most significant limitations of this study include 
the small sample size, largely middle class, Caucasian 
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population, as well as a self-selected group of women who 
voluntarily responded to letters or newspaper solicitations, 
so the results should not be generalized to all women with a 
maternal history of breast cancer. 
Al though the women were demographically similar, the 
findings revealed a tremendous range in the psychological 
picture and in the health behaviors practiced by these women. 
For example, (1) the reported anxiety scores ranged from a 
score of 32 to 77 (the mean score is 50). ( 2) Reported 
depression scores ranged from 34 to 81. (3) Reported breast 
self-examination frequency ranged from not practicing BSE at 
all to performing BSE more than once a month. Therefore, no 
matter how robust the intervention might be, with this diverse 
range, it is not surprising that few statistically significant 
differences were found between the two groups. 
Another factor to consider is that eventhough the 
experimental group demonstrated an increase in knowledge due 
to the breast cancer classes, two - two hour classes may not 
be powerful enough to alter anxiety levels when countered with 
the experience of your mother receiving treatments for breast 
cancer. 
Another limitation of this study was the use of self-
report measures to assess psychological factors among the 
population sampled. When self-report measures are used a 
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"halo" effect (presenting oneself in the best light) must be 
considered. Considering this effect, subjects might be 
exaggerating their reported health behaviors as well as under-
reporting their feelings and fears. 
Another limitation to be considered is the difficulty 
maintaining a "pure control group" given the design of this 
study. The results of the study may have been "contaminated" 
due to the confounding effect of the control group receiving 
questionnaires that possibly may have promoted health-
protective behaviors. 
One disappointment with this study centered around the 
Hoyt reliability coefficient result of 0. 65 for the Breast 
Cancer Questionnaire. These results warrent reevaluation and 
further exploration of this questionnaire in order to improve 
the internal consistency. For example, developing specific 
domains within the test with item subscales, may potentially 
increase the internal consistency of this questionnaire. The 
development of this questionnaire was centered around the 
specific material that was presented during the classes. It 
was never the intention of this study to develop a 
standardized instrument to measure knowledge of breast cancer. 
In order to strengthen the results of this study, it 
might have been better to use a second instrument to measure 
the psychological variables. Several instruments to consider 
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would be the Profile of Mood States or the State/Trait Anxiety 
Scale. 
DISCUSSION 
According to D' Onofrio ( 1980), a proponent for 
emancipation in patient education, "education must foster open 
sharing of information, questions, doubts and concerns, so 
that providers and consumers of health care can learn from 
each other" (pg. 278). Given the present "state of the art" 
with breast cancer information, this philosophy of honesty and 
sharing is critical. The attempt was made to create this type 
of atmosphere for the exchange of information during the 
breast cancer classes that the experimental group attended. 
The goal was to encourage the daughters to learn the facts and 
dispel the myths about breast cancer, and motivate them to 
develop a lifestyle of healthy behaviors. 
Knowledge About Breast Cancer 
The findings from this study demonstrating that both 
groups were homogeneous in their pretest knowledge (Time 1), 
adds to the robustness of the statistically significant 
differences between the groups shown at posttest (Time 2), 
which continued 6-12 months later (Time 3). It can be assumed 
that the breast cancer classes contributed to the increase in 
knowledge scores in the experimental group. These results are 
encouraging. The women in the experimental group reported both 
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verbally and in their evaluations their sense of appreciation 
for the increased knowledge gained by attending the classes. 
One obvious explanation for the fairly good pretest (Time 
1) knowledge base is the tremendous explosion of information 
constantly being presented to the public about breast cancer. 
Most of this influx of information originates with the 
consumer/women's movement of the late 1970's and early '80's. 
Women became much more involved in the many different issues 
that surround the diagnosis of breast cancer. This 
involvement can be seen in the change from "being told what to 
do without having a say", to becoming a partner with the 
health care team in choosing their treatment options. Women 
diagnosed with breast cancer have become much more open about 
the disease. Many women diagnosed with breast cancer present 
to the health care team with a more sophisticated knowledge 
base from which to ask more stimulating questions about the 
causes and treatments for the disease. This surge of energy 
has also been felt as a major political force that demands 
answers and action to the many unanswered questions 
surrounding breast cancer. The most recent transfer of $210 
million new dollars for breast cancer research from the 
Department of Defense budget is an example of this political 
force (Y-Me Newsletter, 1992). 
The need for educational programs for oncology patients 
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has been recognized and addressed for quite some time now 
(Schwartz, 197 7). Several studies have demonstrated that 
cancer patient education can improve knowledge, attitudes, 
health status and possibly health behaviors (Dodd, 1982; Dodd, 
1983; Cassileth, Heiberger, March and Stutton-Smi th, 1982; 
Cassileth, Zupkis, Stutton-Smith, 1980; Johnson, 1982; Jacobs, 
Ross, Walker, and Stockdale, 1983). 
In a comprehensive article discussing cancer patient 
education, Rimer, Keintz and Glassman (1985) recommended 
several future directions that included: 
(1) increasing the amount of efforts for patient 
education, (2) having more broadly trained health 
educators, (3) refining cancer education for more 
specific points along the cancer care continuum, such as 
diagnosis, treatment issues, pain control, long-term 
survivor issues and (4) screen and track patients into 
different educational options according to their needs. 
(p. 815). 
This present study attempted to incorporate several of 
those suggestions by extending the invi tiation for educational 
opportunities to include specific family members, as well as 
refining the educational program to a specific end of the 
continuum, i.e. the early-detection end. 
Awareness of Perceived Risk 
As was previously discussed, women with a maternal 
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history of breast cancer have approximately a 20 percent 
chance of developing the disease. Pretest results of this 
study showed that both groups significantly overestimated 
their chances of developing breast cancer. There are 
conflicting reports in the literature surrounding perceived 
awareness of risk by this group of women for developing breast 
cancer. Most studies would agree that women with a family 
history have vague and erroneous perceptions of risk to self 
by either overestimating or underestimating their likelihood 
of developing breast cancer. 
Kelly (1980) reported on a small, self-selected group of 
women whose mothers had breast cancer, and found that "despite 
their own anxiety and prevailing belief that their own risk 
was increased, most daughters had only vague and erroneous 
information about their own risk" (p. 123). Twenty women (51 
percent) of her sample reported their risk was much "higher 
than average", and four of the 20 women felt certain to get 
breast cancer, while only two women felt their risk was lower 
than the average woman's risk. 
In another study by Kash, Holland, Halper and Miller 
(1992), 76 percent of women whose mothers had breast cancer 
reported a moderate to extreme risk for developing breast 
cancer, while 24 percent of the women thought their chances 
were low to none at all, "despite coming to a program for 
women at high risk for breast cancer". 
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Wellisch and colleagues (1991) reported that women with 
a breast cancer history (80 percent) compared to a group of 
women with no history (22 percent), perceived their chances of 
developing breast cancer to be significantly higher than the 
control group (p <0.0001). 
One of the strengths of the present study is that the 
women had to report a specific percentage of risk to self, 
whereas in the above studies, the women only had to define 
their risk by categories such as, high, moderate, low or 
likely or unlikely to develop breast cancer. 
The positive effects of the breast cancer classes is 
evident by the experimental group reporting a more accurate 
sense of risk to self at Time 2 (post test) and Time 3. In 
addition to an increase in knowledge about breast cancer, 
providing the women with a more accurate sense of risk is 
another major benefit from the breast cancer classes. One 
hypothesis might be that if the daughters are more accurate in 
their estimations of risk to themselves, then on some level 
they may feel less anxious about developing breast cancer. 
Many of the participants reiterated this suggestion by 
commenting that they "can now feel both a little more relaxed 
and an improvement in their quality of life". In addition, 
overestimating risk may lead to or be related to a sense of 
helplessness that, if untreated, could lead to a lower rate of 
early detection behaviors. 
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The intent of the information presented in the classes 
was to give these women with a family history a general idea 
of their risk for developing breast cancer some day. Because 
of the nature of this study, it was not possible to provide 
individual specific details for each woman's own risk. In the 
future, the strength of these classes is that small groups of 
women would receive general risk information and through 
discussions, it could be determined who might need a referral 
for specific risk analysis counseling. 
Psvchological Variables 
Another purpose of this study was to identify 
psychological factors (anxiety, depression and somatization) 
that may or may not be affecting women with a maternal history 
of breast cancer and assess the impact of receiving 
information about breast cancer on these variables. 
According to the SCL-90-R Manual-II (Derogatis, 1983) the 
three variables are defined as follows: 
(1) the anxiety dimension is composed of a set of signs 
and symptoms and cognitive aspects that involve nervousness, 
tension and trembling, panic attacks, and feelings of terror, 
apprehension and dread. 
(2) The symptoms of the depression dimension are fairly 
broad in range and include symptoms of dysphoric mood and 
affect, feelings of hopelessness and thoughts of suicide, 
which are reflected in signs such as withdrawal of life 
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interest, lack of motivation and loss of vital energy. 
(3) The somatization construct reflects distress arising 
from perceptions of bodily dysfunction. Signs and symptoms 
include: headaches, faintness and dizziness, cardiovascular 
and gastrointestinal symptoms, weakness, hot or cold spells, 
pains in lower back, numbness or tingling in parts of the 
body. All symptoms can be associated with true physical 
illness, therefore caution is required when interpreting this 
construct in certain medical populations (Derogatis, 1983). 
Regardless of the symptom dimension, a T score of 50 on 
the SCL-90-R represents the mean score, and a T score of 70 
represents a clinically significant score. Because both 
groups were within the mean scores of the general population 
on anxiety, depression and somatization, the results indicated 
a "fairly normal" psychological picture for this high-risk 
group of women. 
The results of the daughters' reported anxiety scores in 
this study are somewhat surprising and are lower than expected 
for this group of women, given past reports in the literature. 
Royak-Schaler and Lieff-Benderly (1992) describe in their book 
that "the day that daughters learn of their mother's breast 
cancer, is the day the world changes-the day they learn that 
they belong to a high-risk group. This may be the day they 
begin to confront their own mortality" (p, 40). 
Kelly ( 1980) reported the results of structured interviews 
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with 39 women who have a maternal history of breast cancer. 
All but two spontaneously reported "considerable and pervasive 
anxiety about breast cancer because of their mother's 
diagnosis". According to these women, "the anxiety is ever 
present, sometimes brought to the surface by a newspaper 
article, or learning that a friend or relative has just been 
diagnosed, or by their own illness, even if it's just a cold" 
(p. 121). A major difference of this study compared to the 
present one is that the information about anxiety is gathered 
from interview data and not from a standardized instrument. 
Kash, Holland, Halper and Miller (1992) report that women 
at "high risk were almost one standard deviation above the 
mean on all measures of psychological distress on the Brief 
Symptom Inventory". On two of the subscales, depression and 
psychoticism, the women were greater than one standard 
deviation above the mean. (The authors point out that the 
psychoticism scale is frequently elevated in physically ill 
patients due to their sense of isolation related to their 
illness) . The authors report "that with the use of 
standardized cutoffs, 27 percent of these women were defined 
as having a level of psychological distress consistent with 
the need for psychological counseling" (p. 28). 
Kash and colleagues (1992) used the Brief Symptom 
Inventory ( BSI), which is the brief form of the SCL-90-R. 
Correlations between the symptom dimensions of the SCL-90-R 
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and the BSI are based on 600 psychiatric patients and range 
from .92-.99. More than likely, the inconsistency in anxiety, 
depression and somatization scores between the two studies is 
probably not related to differences in the measure. 
One possible reason for difference in this psychological 
picture between Kash and colleagues ( 1992) study and the 
present study may be related to eligibility criteria. 
Eligibility for the Kash study required two or more first-
degree relatives (mother, sister and/or daughter} with breast 
cancer, a first-degree relative with premenopausal breast 
cancer or a mother and maternal grandmother with breast 
cancer. This difference may account for the higher anxiety 
levels reported, since most women with two or more first-
degree relatives would be at a considerably higher risk than 
the woman in this study. (Four women in the experimental group 
and one women in the control group had two first-degree 
relatives). 
The results of the anxiety scores from this study are in 
contrast to previously reported studies, Most information 
from past studies is based on interview and anecdotal data 
without the use of standardized instruments (Kelly, 1980; 
Rosenfeld, Caplan, Yaroslavsky et al, 1983; Lamb, 1984; 
Lichtman, Taylor, Wood et al, 1984). 
In addition to methodological weaknesses in past studies, 
another explanation for this difference in the psychological 
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picture of this high-risk group of women may be related to a 
"developmental process". One might hypothesize that these 
women may be maturing in their abilities to cope with this 
chronic disease. Several factors may contribute to this 
"maturing or growth" on the part of the daughters: (1) living 
in a more open and communicative environment which allows for 
more discussion about the issues of breast cancer. (2) The 
daughters may be experiencing more honest communication with 
their mothers. One element that was not addressed in this 
study, is that possibly these women have mothers who are 
better able to cope with their own breast cancer and therefore 
communicate, either through cognitions and/or behaviors to 
their daughters a less anxious style. This "mature coping 
style" may translate into a more "normal" psychological 
picture for the daughters. 
The study by Wellisch and colleagues (1991) also report 
surprising and similar results to this study. Using the BSI, 
the authors reported that there were no significant 
differences between daughters whose mothers had breast cancer 
and a comparison group on any of the nine symptom subscales. 
In addition, the scores for both groups were in the normal 
range on all symptom subscales. The authors cite two possible 
explanations: ( 1) a possible "buffering effect from stress 
patterns due to advanced education and relative affluence and 
(2) the participants were not coming to medical clinics 
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seeking help for symptoms and concerns" (p. 332). 
Both explanations could possibly account for the women in 
this present study, al though, relative affluence was not 
evaluated. In addition, discussions that took place after 
the post-tests were completed revealed that many of these 
women were dealing with the usual daily stresses that 
accompany carrers and family responsibilities. Therefore, it 
seems more likely that only the second suggestion may apply to 
the participants in this study. 
One of the initial concerns in the development of this 
study, was that attendance at a class in which a high-risk 
group of women would receive information about breast cancer 
would cause an increase in anxiety, depression and 
sornatization rather than decreasing these psychological 
variables. 
A study by Berg, Alt, Himmel and Judd (1985) looked at a 
rheumatoid arthritis patient education program and its effects 
on knowledge and psychological variables (depression and 
anxiety). All patients felt the program was beneficial, the 
content had met their needs and every subject demonstrated an 
increase in disease-related knowledge. However, the authors 
reported a "heightening in the correlation of the AIMS anxiety 
score (Arthritis Impact Measurement Scale), with AIMS physical 
factors at post-test, as well as an increase in AIMS 
depression levels, which suggested that a gain in knowledge 
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about their disease caused an increased concern about their 
condition" (p. 393). At follow-up testing this correlation 
was no longer seen. These data suggest that patient education 
may have "an immediately deleterious psychological effect in 
patients with more severe disease" (p. 394). This study is in 
contrast to other literature regarding the impact of 
information on psychological variables. 
Other studies have addressed the impact of patient 
education on psychological variables and suggest that 
information reduces anxiety by increasing feelings of control 
(Anderson, 1978; Lazarus, 1966; Melamed and Siegel, 1975; 
Flam, B., Spice-Cherry, P. and Amsel, R., 1989). Several 
other studies have demonstrated little or no change in anxiety 
levels (Hillier, C. and Slade, P. , 1989). In a control led 
study (Johnson, 1982) reported that anxiety, meaningfulness in 
life and knowledge all improved following an educational 
program. 
In summary, there are only a few studies that have 
empirically documented the psychological status of women with 
a maternal history of breast cancer. Although this study did 
not demonstrate any statistically significant differences in 
psychological variables between the two groups, there was a 
trend of decreasing anxiety, depression and somatization 
scores in the experimental group after attending the breast 
cancer classes. In fact, given the unknown timeline 
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parameters necessary for developmental change, it may be that 
the decreases found in this study were meaningful in the lives 
of these individuals although not found to be statistically 
significant within the time frame assessed. 
Based on the results of this study as well as Wellisch and 
colleagues ( 1991), daughters with a maternal history of breast 
cancer may not be as psychologically distressed as earlier 
reports would conclude. Health care professionals should be 
aware that there is probably a significant range to the 
psychological picture of these women and that future studies 
must focus on screening and predicting for those in need of 
psychological counseling. 
Health Behaviors 
Screening is the process of looking at healthy 
individuals with no signs or symptoms, in order to detect 
early signs of a disease (Love, 1991). For many years, the 
American Cancer Society has provided guidelines for early 
detection screening practices. The recommendations are 
reviewed and changed periodically as additional information 
and technologies become available. The ACS has made efforts 
to determine that the recommendations are practical, feasible 
and cost effective, and that the benefits outweigh the costs. 
At the present time the ACS recommends the following early 
detection breast cancer screening guidelines: 
(1) Women older than 20 years of age should perform monthly 
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breast self-examination (BSE). There are suggestions from 
several National Breast Cancer Organizations that BSE 
education begin in the senior year of high school. 
(2) Women between 35-40 years of age should have their first 
mammogram. For women with a first-degree relative with breast 
cancer the recommendation includes having a first mammogram 
approximately five years earlier (around 30 years of age). 
(3) Women between 40 and 50 years of age should have 
mammograms every two years and physical examination of the 
breast every year. 
(4) Women older than 50 years of age should have annual 
mammograms and annual physical examinations (Dodd,1992). 
The use of mammography as a screening method is 
considered to be the most effective technique currently 
available for the early detection of breast cancer (Shapiro, 
1989; Tabar and Dean, 1987). In this country, the use of 
mammography has significantly increased. Studies done between 
1978 and 1983 indicated that only 15-20 percent of women in 
the United States reported ever having had mammograms (Howard, 
1987). However, by 1990, based on the Mammography Attitudes 
and Usage Study (MAUS) two-thirds of women aged 40 and over 
reported having had at least one mammogram. However, only 35 
percent of the women reported more than one mammogram, and 
less than one-third (31 percent) were· following national 
screening guidelines (Marchant and Sutton, 1990). Although 
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use has increased, minority women, older women and those with 
less income and education continue to be under-utilizers. "The 
lack of physician recommendation remains the most important 
barrier to utilization. Even with no charge mammography, 
compliance is often disappointing'' (Rimer, 1992, pg. 201). 
The findings in this study indicate that at pretest 77 
percent of women in the experimental group and 75 percent of 
the control group, 30 years of age or older, reported having 
obtained a mammogram. These results are one of the highest 
reported for this high-risk group of women reporting 
mammography utilization. Among first-degree relatives, 
previous studies report much lower results (32-66%) for 
mammography screening practices (Krischer, Cook and Weiner, 
1988; Vogel et al 1990; Wellisch et al, 1991; Stefanek and 
Wilcox, 1991). 
To better understand the impact of the breast cancer 
classes on mammography utilization, all women were reevaluated 
according to age-appropriateness and symptomatology for 
obtained or unobtained mammograms between Time 1 and Time 3. 
In the experimental group, six of eight women who had not 
obtained a mammogram at either Time 1 or Time 3 were 
appropriate in mammography utilization. The other two of 
eight were 30 years of age or older, had not had a baseline 
mammogram, but had been told by their physicians to wait until 
35 years of age. Two women who should have had a baseline 
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mammogram at Time 1 but did not, obtained mammograms after 
attending the breast cancer classes. Eleven women reported 
having had mammograms at Time 1 but not at Time 3. For six of 
the eleven this was appropriate, five of the eleven reported 
having had baseline mammograms, however they were all under 27 
years of age. The five women who reported having had 
mammograms at both Time 1 and Time 3 were appropriate 
utilization based on symptoms. 
Thirty women in the control group were evaluated for 
mammogram utilization between Time 1 and Time 3 based on age 
and symptomatology. Results indicated that 2 7 women had 
complete information and three were missing data. Twenty-one 
out of 27 women (78 percent) were appropriate in mammogram 
utilization according to their age and symptoms. Four out of 
27 (15 percent) were inappropriate in their mammogram 
utilization. For example, two women were obtaining mammograms 
too frequently (every six months without symptoms), one woman 
should have obtained a mammogram given her age and family 
history, and one woman was too young ( 25 years) to have 
obtained a mammogram. The remaining two women (7 percent) 
were 30 years of age, had not had baseline mammograms but were 
told by their physicians to wait until 35 years of age before 
obtaining them. 
These results are somewhat surprising given the reports 
in the literature on mammography utilization by first-degree 
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relatives with breast cancer. Several possible explanations 
include: (1) the difference between appropriate and 
inappropriate mammograms obtained between the two groups may 
be related to the breast cancer classes. (2) It may be that 
the public educational promotions for breast cancer over the 
last 10 years have affected this group of women. (3) For those 
women in the control group who were appropriate in their 
mammography utilization, the "Hawthorne effect" may be playing 
a part, (participating in the study may have served as 
reminders to obtain mammograms). 
The few women in the present study who had not obtained 
mammograms explained that given their age, some of their 
physicians were not recommending mammography until age 35 or 
40, or were recommending mammograms every other year or on a 
"whenever necessary" schedule. 
Although most oncology specialists would recommend 
baseline mammograms at approximately 30 years of age for 
first-degree relatives, the answers are still unknown as to 
what is the most appropriate follow-up screening schedule for 
this high-risk group. 
Rimer ( 1992) reviewed the mammography 1 i terature and 
discussed factors surrounding routine screening habits of 
American women. The author discussed an article by Lerman and 
colleagues (1990). Using 1988 breast cancer survey data, the 
authors compared women who had one mammogram versus more than 
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one and found that "women who reported more than one mammogram 
were more likely to have had a family history of breast 
cancer, physician recommendation for mammography and perceive 
a greater personal vulnerability to breast cancer" (p. 199). 
A later survey by Rimer and colleagues (1990) looked at 
women who had obtained one versus two mammograms and found the 
major contributing factor was again physician recommendation. 
Rimer's (1992) conclusion is that a "combination of physician 
recommendation, knowledge and sociodemographic characteristics 
accounted for repeat mammograms" (p. 199). 
Of interest, at Time 3, the question was asked, "How 
many mammograms have you had in your life"? Surprisingly, a 
total of 11 women in both groups had obtained three or more 
mammograms in their life, with 2 women in the control group 
who had obtained 5 mammograms. 
After reviewing the data for the women who had obtained 
three or more mammograms, it appeared that symptoms such as: 
calcifications, a lump in the breast or bleeding from a nipple 
accounted for the increased number of mammograms among these 
women. 
In summary, the findings indicated that the majority of 
women in this study are following recommended guidelines for 
mammography screening, which is a significant improvement over 
past studies reporting screening practices for this high-risk 
group. In spite of the lack of statistically significant 
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differences between the two groups, the breast cancer classes 
appear to have contributed to mammography utilization by 
motivating four women 30 years of age or older who had not 
obtained mammograms prior to Time 1 and to obtain them by 
Time 3. 
Breast Self-Examination: There is considerable debate over 
the usefulness of breast self-examination (BSE) as a screening 
method for breast cancer. Although BSE is a simple, 
noninvasive and inexpensive screening method, with some 
studies suggesting its effectiveness by detecting breast 
cancer at an earlier stage (Huguley, Brown, Greenberg and 
Clark, 1988; Hill, White, Jolley and Mapperson, 1988; Shwartz, 
1992); it's effectiveness has yet to be scientifically 
determined (Newcomb, Weiss, Storer, Scholes and colleagues, 
1991; Morrison, 1991). O'Malley and Fletcher (1987) reviewed 
evidence on the value of screening with BSE and concluded that 
"many unanswered questions remain and require scientific 
investigation before this method can be advocated as either a 
supplemental or as a primary screening test for breast cancer. 
The problem with BSE is not evidence of a lack of effect, but 
lack of evidence" ( p. 2202). 
This controversy over BSE's usefulness has caused 
differences in recommendations from health care agencies. For 
example, the ACS and Y-ME National Breast Cancer Organization 
continue to recommend BSE as one of the three established 
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methods for early detection of breast cancer. Within the 
National Cancer Institute there appears to be confusion as to 
whether to recommend BSE or not (Mayer and Solomon, 1992). 
Some of these questions surrounding early detection 
screening methods for breast cancer are being addressed in the 
National Breast Cancer Screening Study of the NCI of Canada. 
This study compares annual mammography in postmenopausal women 
to an initial mammogram, annual clinical examination and 
instruction in BSE (Fisher, Osborne, Margolese and Bloomer, 
1993). 
In spite of the controversy regarding the effectiveness 
of BSE, it seemed appropriate to include a review of BSE in 
the breast cancer classes, since 85-95 percent of breast lumps 
are detected by women themselves. 
The results of this study indicated that at Time 1, 91 
percent of the experimental group and 90 percent of the 
control group had performed BSE. The results also indicated 
that the mean time since last performing BSE was 2.5 months 
for the experimental group and 3. 5 months for the control 
group. Overall, there were minimal changes in the practice of 
BSE between Time 1 and Time 3. In the experimental group, 
thirteen women did not change their frequency, six women 
increased their frequency and four decreased their frequency. 
In the control group, fourteen women did not change their 
frequency, seven women increased and three decreased their 
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frequency. 
The recommended frequency is monthly and the results 
showed that 84 percent of the experimental group and 66 
percent of the control group are performing BSE within the ACS 
guidelines. Since the majority of these high-risk women were 
already practicing BSE at a correct frequency, the numbers are 
too small to see statistically significant differences in the 
frequency of BSE practice between the two groups. 
Only one report in the literature is consistent with the 
results of this study. Kelly (1979) reported that out of 158 
women who attended a clinic for "breast concerns", 66 percent 
of the women surveyed practiced BSE and 80 percent of those 
who examined their breasts tended to do so at least once a 
month or more. However, it is unclear whether the women in 
this study had a family history of breast cancer. 
The results from this study and Kelly's (1979) differ 
from other reported studies of BSE practice among high-risk 
women. Most studies indicate less than a 50 percent monthly 
frequency rate of BSE practice (Alagna, Morokoff, Bevett and 
Reddy, 1987; Wellisch, Gritz, Schain, Wang and Siau, 1991; 
Krishcer, Cook and Weiner, 1988). 
Possible Relationship of BSE and Anxiety. 
The fairly normal to moderate levels of anxiety found in 
this group of women may account for their improved early 
detection screening practices. In a the study by Lerman, 
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Trock, Rimer and Jepson (1991), the authors report that women 
with "moderate levels of worry impact are more likely to 
practice monthly BSE than women with either high or low levels 
of impairment" (p.265). 
The Lerman and colleagues ( 1991) findings correlate well 
with conclusions drawn by Kash, Holland, Halper and Miller 
( 1991). The authors suggest "that high levels of anxiety 
impaired adherence to both regular clinical breast 
examinations and performance of BSE" (p. 30). 
There is no certainty that the women in this study were 
practicing BSE as reported or performing BSE accurately. The 
women were asked at Time 1, "has anyone ever taught you breast 
self-examination?" It was encouraging to learn that the 
majority of the women reported receiving BSE instruction from 
a nurse or physician (26% from nurses; 59% from physicians and 
15% from pamphlets), since it has been found that women taught 
BSE by a nurse or physician perform more of the necessary 
steps (Laughter, Kean and Drean, 1981). 
In order to better understand BSE practice among this 
high-risk group, the women were asked their reasons for doing 
BSE. In the experimental group, reasons for doing BSE were: 
"in order to check for lumps" (24 women); "family history" 
( 1), "protect myself against cancer" ( 1) and "I'm suppose to" 
( 1 ) . In the control group, reasons for doing BSE were: "to 
check for abnormalities" ( 14), "family history" ( 6) "early 
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detection" (3) and "it's a healthy thing to do" (1). 
For future studies Mayer and Solomon (1992) offer the 
following recommendations for measuring and reporting BSE 
frequency: ( 1) "give subjects permission" to report non-
adherence or low adherence". ( 2) In order to make comparisons 
across studies, reporting mean numbers of BSE' s and time 
intervals in which they were measured would be helpful. (3) 
Use a "user-friendly" method for measuring BSE performance 
that is consistent and acceptable to subjects (Mayer and 
Solomon, 1992). 
Conclusions 
Overall, the impact of the didactic group experience on 
women with a maternal history of breast cancer was a positive 
one. Knowledge about breast cancer increased, awareness of 
risk to self became more accurate and anxiety, depression and 
somatization levels did not increase with more information. 
The surprising and encouraging findings indicated that the 
majority of women in this study reported following recommended 
guidelines for mammography screening and BSE frequency, which 
is a significant improvement over past studies reporting 
screening practices for this high-risk group. 
A strength of this study is that both groups of women 
were followed from 6-12 months after their initial 
participation in order to assess for any possible negative 
consequences of receiving the breast cancer information. 
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Results indicated that no rneasureable negative consequences 
occurred as a result of attending the classes. 
The women in the experimental group were asked to 
evaluate the breast cancer classes based on class content, how 
well the classes were taught and whether they would like to 
hear more about breast cancer. The majority of these women 
evaluated the didactic group experience as 
worthwhile". 
"extremely 
Negative comments included: classes were too long; a more 
current BSE video should have been used; presentation style of 
the class material was too fast; and the class content was too 
simplistic. After the posttests were completed, discussion 
among the participants was encouraged in order to gather 
suggestions on how to improve the classes. 
Most of the women acknowledged difficulty hearing the 
information about this threatening disease, however the 
majority felt it was rewarding to dispel myths and receive up-
to-date information about breast cancer. Many commented that 
a reward for attending the classes was the opportunity to meet 
other women who shared their same concerns and who are living 
with similar experiences. In fact, some of the participants 
expressed frustration with the format of the classes and 
wanted more of a support group approach. 
In spite of scheduling hassles, babysitting difficulties, 
and inconveniences, such as driving great distances, the 
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majority of the women reported that they greatly appreciated 
these classes and would appreciate more opportunities like 
this one made available to them. 
Implications for Psychological Interventions 
Although sample size limits the generalizability of 
conclusions which can be drawn from this study, the findings 
contribute toward a better understanding of women with a 
maternal history of breast cancer. Strengths of this study 
included using a randomized design and a standardized measure 
to assess the impact of the classes and to measure 
psychological variables in this "at-risk" group. 
This study helps to demonstrate that organizing and 
formalizing breast cancer classes are both feasible and 
appreciated, and over time, can probably demonstrate economic 
benefits given their success at promoting early detection 
behaviors related to both psychological and medical factors. 
The women who participated in this study expressed 
appreciation that their needs and concerns had been identified 
and that opportunities for receiving information and support 
were available to them. 
Part of the success of these classes had to do with the 
overall atmosphere that was created for these women. As Kelly 
(1979) suggested, "educational campaigns that produce fear are 
likely to be less effective than those that inform in a less 
anxiety-producing manner" (p. 37). 
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This present study was an outgrowth of several 
recommendations for future research addressed by this author 
in a master's thesis. The intent of this study was to provide 
a first step toward addressing the need for the development of 
educational interventions for women with a family history of 
breast cancer. Using this study as a guide, the continued 
goals for future research and psychological interventions 
should be to decrease distress, provide education, improve the 
practice of early detection heal th behaviors and thereby 
promoting early detection of breast cancer. 
One implication from this study that needs to be 
addressed when developing future intervention studies is the 
significant amount of time and energy that was required in 
order to overcome the difficulties of accessing, recruiting 
and maintaining participants for this study. 
Another implication from the findings of this study 
suggest that it may be immediately feasable to incorporate the 
format and content of these classes into an ongoing 
educational program for already existing Comprehensive Breast 
Centers. These centers are growing at a significant rate, and 
as the name implies, comprehensive should extend to include 
not just patients but also all women (daughters and sisters) 
with a family history of breast cancer. 
A new area that has developed to promote education and 
support is the Breast Cancer Risk Analysis service. Such a 
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service is designed to provide information about a woman's 
risk, background information regarding etiology of breast 
diseases, risk factors, and provide guidance for appropriate 
breast health care. In addition, women and their families can 
find social and psychological support from this specialized 
service (Kelly, 1991). 
Al though breast cancer screening, as well as breast 
cancer risk analysis have the potential for decreasing 
morbidity and mortality, consequences of receiving information 
about breast cancer risk and/or early detection breast cancer 
screening results may have potentially negative psychological 
side effects. This is a new area for health psychology 
research. Several recent articles have begun the discussion 
surrounding the psychosocial and ethical implications for this 
area that need to be addressed (Lerman, Trock, Rimer, Jepson, 
Brody and Boyce, 1991; Lerman, Rimer and Engstrom, 1991). 
Specific Research Directions 
Specific recommendations for future research include: 
(1) more studies are needed to assess presently used 
instruments (SCL-90-R, BSI, State-Trait) in order to determine 
the most accurate measure with which to better predict those 
family members who may need psychological interventions. 
(2) More studies are needed using large sample sizes of 
daughters and sisters, to assess similarities and differences 
in psychological variables and coping styles. In addition, the 
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different developmental life-phase issues that affect these 
women should be evaluated, including specific issues such as 
body image and sexual functioning. 
(3) Future studies might correlate coping styles of women with 
breast cancer and the coping styles of their daughters. For 
example, how are the mothers and their daughters similar 
and/or different in their approach to seeking information as 
well as their compliance with early detection screening 
practices. 
( 4) One major research question at this time concerns the 
value of support groups. Based on comments from the women 
in this study, as well as two studies in the literature, 
(Jacobs and colleagues, 1983; Mumford and colleagues, 1982) 
an interesting approach would be to use a randomized, three-
arm study design to examine outcomes comparing a purely 
educational program, versus a peer support group therapy or a 
combination of the two. 
( 5) Additional studies are needed that focus on improving 
early detection screening practices of non-White women and 
women of lower socioeconomic status who have a family history 
of breast cancer. 
(6) Another future direction would be to examine physician 
recommendations for early detection screening practices for 
breast cancer. Based on several reports in the 1 i terature 
already cited, lack of physician recommendation is one major 
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barrier contributing to women following recommended screening 
guidelines. Focusing attention on the physician may be an 
important step for health psychology. 
Identifying and assessing psychological interventions for 
women with a maternal history of breast cancer is a new and 
exciting area for heal th psychologists. In addition to 
counseling for the emotional concerns about their mother's 
illness, adult and adolescent daughters, as well as sisters, 
would undoubtedly benefit from interventions that provide: 
(1) accurate information about breast cancer in general with 
specific emphasis on risk factors, which must be individually 
assessed. 
(2) Understanding the most effective ways to educate, motivate 
and sustain early detection health behaviors that match 
individual styles of coping by the daughters and sisters. 
(3) Understanding the particular barriers that each woman may 
have that prevent the routine practice of health behaviors. 
(4) Assessment of individual coping styles as healthy versus 
unhealthy for each individual daughter and sister, while 
understanding and respecting various coping methods. 
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Breast cancer effects one out of nine American women 
during their lifetime (ACS, Facts & Figures, 1992). 
Al though breast cancer continues to be one of the major 
causes of cancer death among women, the five-year survival 
rate for localized breast cancer detected early is 
approximately 92 percent (ACS, Facts & Figures, 1992). 
The principle risk factors for breast cancer include: 
family history, age and menstrual and reproductive history. 
Clearly, the most significant risk factor is heredity. 
Women who have a first-degree relative (mother or sister) 
with breast cancer have a risk two or three times that of 
the general population (Sattin, Rubin, Webster and 
colleagues, 1985). The survival rate is directly related 
to the size of the breast tumor. The larger the lesion, 
the greater the chance that metastases have occurred. 
Therefore, early detection of breast cancer remains an 
essential key to increased cure rates and survival. 
There are three established methods of early detection: 
physical examination, mammography and breast self-
examination (BSE). Educating women about these three 
methods is critical to early detection of breast cancers. 
Identifying the population that is most in need of early 
detection and finding the best method to educate women has 
been a major focus in recent research proposals. 
136 
Women with a maternal history of breast cancer have 
been identified as a "high-risk" group. With breast cancer 
specifically it is likely that daughters will be emotionally 
effected by the chronicity of their mothers' disease, 
however, they may or may not develop a sense of being at 
risk themselves. Several authors have identified the need 
for increased education for this group of women for several 
reasons: (1) more information may decrease potentially high 
anxiety levels that these women may be experiencing and (2) 
more education may increase the use of early detection 
methods (Kelly, 1980; Kelly, 1987; Lichtman, Taylor, Wood, 
Bluming and colleagues, 1984 and Taylor, 1987). Therefore, 
it seemed timely to test several questions that need to be 
addressed in this "at-risk" population. 
include: 
The questions 
(1) what do women with a maternal history of breast cancer 
understand about the disease? 
(2) What do women with a maternal history of breast cancer 
perceive their own risk to be for developing the 
disease? (3) What is the psychological impact of 
receiving information about breast cancer? 
(4) What early detection behaviors do these women practice? 
(5) Does this "at risk" group comply with recommended early 
detection methods set forth by the American Cancer 
Society? 
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investigator or the nurse conducting the classes. Their 
occupations included: a nurse, make-up artist, realtor, office 
administrator, and advertising copywriter. Their educational 
levels ranged from two years of college to completion of post-
graduate work. A total of seven women agreed to attend the 
classes, however only five women were able to complete the two 
classes. The classes were held at the home of the nurse 
conducting the classes. 
Results and Discussion 
Al 1 five women completed all 
questionnaire asking about heal th 
awareness of risk for breast cancer. 
of the questions on the 
behaviors practiced and 
In addition, all women 
completed the Breast Cancer Knowledge questionnaire, which 
included twenty-five true/false questions given before and 
after the classes. 
In response to the question, "What percentage best 
describes your chance of developing breast cancer some day?" 
Four of the five women over-estimated their chances of 
developing breast cancer ( +5% to +20%). 
estimated her risk by -5 percent. 
Responses to questions concerning 
One woman under-
early detection 
behaviors practiced revealed the following information: 
(1) none of the five women practiced BSE on a regular basis. 
(Once a month is the recommendation). 
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(2) One of the five women had obtained a baseline mammogram. 
(Three of the five are in the appropriate age range to have 
obtained a mammogram). 
(3) Of the four women who had not had a baseline mammogram, 
only one intended to get one after having attended the class. 
Results of the Breast Cancer Knowledge Quesionnaire are 
as follows: 
Sub.iect 
1 
2 
3 
4 
5 
Pretest (%correct) 
76% 
60% 
68% 
41% 
64% 
Posttest (% correct) 
92% 
96% 
100% 
92% 
100% 
These results clearly demonstrate an increase in the 
number of correct answers from pretest to posttest. 
Participants rated the class experience as extremely 
worthwhile. All five agreed that inspi te of scheduling 
di ff icul ties, they'd rather attend two classes and receive 
more information than attend one class and eliminate 
information. However, the fact that two women out of seven 
were unable to commit to the classes was interpreted as a 
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"potential problem area" that may predict accrual problems. 
All five women agreed that the content of the classes was 
excellent as well as understandable. In addition, the women 
agreed that the homework assignment was actually enjoyable and 
a very worthwhile exercise. All five women agreed that the 
length of the classes was very tolerable (each night was 
approximately an hour and a half). 
The participants also offered many other constructive 
suggestions and comments. Examples include: allow for more 
question and answer time and spend more time presenting the 
"statistics" of breast cancer. In addition, the women 
suggested that the nurse take on a slower presentation style. 
In summary, the purposes of the pilot study were 
achieved. In addition, the pilot study proved to be an 
invaluable educational experience for the Oncology Clinical 
Specialist as well as the participants. 
APPENDIX B 
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Dear Study Participant, 
Thank you for agreeing to participate in this study. 
The following packet is the first part of the study. This 
packet has four parts: ( 1) consent form, ( 2) questionnaire 
( SCL-90), ( 3) demographic section that asks heal th-related 
questions about you and your family, and (4) a pretest that 
includes some True\False questions asking about breast cancer. 
Please sign the consent form, read each page carefully 
and answer all of the questions. 
In several months you will be receiving another packet 
similar to this one. Please complete it and return it to me 
as soon as possible. 
All of the information will be coded so that it remains 
confidential at all times. THANK YOU for your cooperation. 
If you have any questions, please feel free to call me. 
Bonnie Taylor, R.N., M.A. 
531 W. Briar Pl. 
Chicago, Illinois, 60657 
312 935 - 9740 
AFTER SEPTEMBER 1st my address will be 
3024 N. Kenmore, 60657 
INFORMATION SHEET / CONSENT FORM 
Because health professionals (psychologists, nurses and 
physicians) would like to better understand how to help 
people deal with risks to their health, I am being asked 
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to participate in this study. This study examines an 
individual's attitudes, feelings and understanding of risks 
to her heal th especially related to her family's heal th 
history. With these results it is hoped that heal th care 
professionals will provide better education to patients and 
their families. 
If I agree to participate I understand that I will be 
expected to complete some questionnaires (requiring 
approximately thirty minutes) and this request will be 
repeated again in about six months. I also understand that 
all study participants will be randomly assigned to either 
attend two educational classes, or be randomly assigned to 
a wait-list and asked to attend the classes at a later date. 
I understand that at no time during the study will I be put 
at risk. If at any time during the study I would like to 
withdraw from participation, I am able to do so without 
penalty or prejudice. If any questions may arise at any 
time during the study the investigator will be happy to 
discuss them. 
All information and responses to questionnaires will remain 
confidential. When the study is written up, only group 
information will be reported and individual subjects will 
never be identified. At the conclusion of the study, those 
interested in receiving a summary of the findings may do so 
by asking the investigator. 
I have read, been given the chance to ask questions, and 
understand the information in this Subject Information Sheet. 
I volunteer to participate based on this information and may 
request a copy of this Information Sheet. 
Volunteer's Signature 
and Date 
Investigator's Signature 
and Date 
I was present during the explanation referred to above, as 
well as the volunteer's opportunity to ask questions, and 
hereby witness her consent to participate in this study. 
Witness's Signature & Date 
DEMOGRAPHIC INFORMATION 
NAME 
ADDRESS 
CITY 
TELEPHONE 
BIRTHDATE 
ZIP STATE 
~~~~~~~~~~WORK #~~~~~~~~~~~-
EDUCATIONAL LEVEL COMPLETED 
High School 
College 
Post Graduate~~~~~ 
ETHNICITY 
African American 
Asian 
Caucasian.~~~~~~~~~~ 
Hispanic 
Other 
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Please turn to next page, 
APPENDIX C 
Demographic Information/Questionnaire 
The following pages will address questions about your 
health and that of your family. Please answer ALL the 
questions. 
(1) Have you ever had a Pap Test? 
NO YES 
(2) If yes, when was your last one? 
(3) What is the MAIN reason you get a Pap Test? 
(4) Have you ever had a Mammogram? 
NO YES 
(5) If yes, when was your last one? 
(6) How often do you get Mammograms? 
(7) What is the MAIN reason for getting your Mammogram? 
(8) Have you ever done Breast Self-Examination (BSE)? 
NO YES 
(9) If yes, when was the last time you examined your 
breast? 
(10) What is the MAIN reason you do BSE? 
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(11) Has anyone ever taught you Breast Self-Examination? 
NO YES 
(12) If yes, who taught you? Nurse Doctor ___ _ 
Other 
( 13) At what age did you begin having periods? ______ _ 
(14) Have you ever used birth control pills? 
NO YES __ _ 
(15) If yes, how old were you when you started 
them? 
(16) What is the total number of years you've taken 
them? ____ _ 
(17) Have you ever had a biopsy of your breast? 
NO 
---
YES __ _ 
(18) If yes, how many times? _______________ _ 
(19) If you have children, how old were you when you 
delivered your first child? 
( 20) How many sisters do you have? ____________ _ 
(21) Have any of your sisters been diagnosed with breast 
cancer? 
NO __ _ YES __ _ If yes, how many? ______ _ 
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(22) Do any other close relatives have breast cancer? 
YES~~~ 
If yes, type of relative, for example, grandmother. 
Mother's Relatives Father's Relatives 
(23) What percentage best describes YOUR chance of 
developing breast cancer some day? 
Answer from 0 to 100% 
(24) What percentage best describes the AVERAGE woman's 
chances of developing breast cancer some day? 
Answer from 0 to 100%~~~~~~~~~~~~~~~~ 
(25) What was YOUR age at time of your mother's breast 
cancer diagnosis? 
(26) What was your MOTHER'S age at the time of her 
breast cancer diagnosis? 
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(27) What was the type of primary treatment your mother 
received for breast cancer? 
Please check all that apply. 
SURGERY 
Mastectomy left ___ _ right 
---
both __ _ 
Lumpectomy left ___ _ right 
----
both __ _ 
RADIATION THERAPY 
CHEMOTHERAPY 
HORMONE THERAPY 
RECONSTRUCTIVE SURGERY 
(28) What do you believe is the cause of breast cancer? 
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APPENDIX D 
Symptom Check List-90-Revised 
Reprinted with permission of Dr. L. R. Derogatis 
SCL-90-R 
INITllUCTIONI: 
....,_le•._ flf,......,... ...i -.&Mnu Nt PNt* 
_._ tww. ,..._MM wtl w ulWfully. After'°" 
.................. Mlllwflf*_..........._IO 
._ riflll IMt ._ ........ NOW MUCH DllCOMFOllT 
THAT "'OILaM HAI CAUllD YOU DUfUNG THI 'AST 
WlllC INCWDINO TODAY .... ._ 9llty - _..,... 
..... ,_,_...,...... ..... llllt.•ny._.H..., 
....,...,.._ ....... _...,flm-••IWfully. RUcltt. 
.......... ~...._ lleglnnirlg ..... ff you MwMy.-· 
..... ...... .. .... 9CtlniciM. 
HOW MUCH Wllll 
YOU DllTllllllD IY: 
1 ..... .,..... 
IEX 
.....__. 
MAI.I 
0 
,._. 
0 
-
HOW MUCH WIRI YOU DllTilllllD IV: 
1. H1111111i.. 
z. ~orlhaldnelalMlde 
J. R1111111d ...,e.wnt ....,, .... ttwt w't e.w your INnd 
•• 
,....._., ..... _ 
•• 
"-..................... 
....................... 
7. ,.. ................... - ....... your thoulh• 
•. ,...... ................... for ........ your ........... 
t.T..-.. ........... 1111 ...... 
10. Wonted ................ ., ....... ,.. 
11. ,...... ...., ....... inttatad 
1Z. ,.._lft"-ter..._ 1J. ,...... ......... .,... ___ ._._ 
"· ,...,. ...... eMlft., ........... 
11. ,.........,, ......... ,... ... 
"· ...................................... , 
17. Ta ....... 
11 ...................................... 
11. ,..,...,.... 
zo. CrytneMally 
Z1. ,_..111y_,__, ..... ._,,., ..... 
zz. ,....... ......................... 
u. a111111111ntv ~ ,_ __ 
Z4. T......, .......... tMt ,_.....,not ....... 
ZI. ,...... .............. ,..,, ........... 
ZI . ....................... 
27. .................. 
H. ................................. 
u . 
...... lellllr JO, ,..... ... 
11 . ....,,... .................. 
u . .................. "' ...... 
II. ........... 
M. Yeur ........ 11e1nt eelly llurt 
11. 0...,...... ............................. 
.._..,.. R. Der9ptia. Ph.D. 
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SIOE 1 
I 
lllAMI; 
LOCATION; 
IDUCATIOfll: 
MAlllTAL ITATUI: -~P--OIV-'MD--91111G-
DATI ID • AGE 
-
DAY YIM ....... 
VlllTfllUllUll: ---
1 (J) CD (1) (1) © 
z (!) CD (1) Cf) © 
I (!) CD CD Cf) © 
• (!) CD CD Cf) © I (!) CD (1) (1) © 
I (!) CD CD Cf) © 
7 (J) CD CD (1) (!) 
• (!) CD CD CD © I (!) CD CD CD (!) 
10 (!) CD Q) CD © 
" 
(!) CD CD CD (!) 
1Z (!) CD (1) CD © 
11 (!) CD CD CD (!) 
14 (!) CD Q) CD © 
" 
(!) CD CD CD (!) 
11 (!) CD Q) CD © 
17 (!) CD (1) CD © ,. (!) CD Q) CD © ,. (!) CD CD CD © 
20 ® CD Q) (J) © 
11 (!) CD (1) CD © 
2Z ® CD Q) CD © 
n (!) CD CD CD © 
14 (!) CD Q) CD © 
• (!) CD CD CD © 
• (J) CD Q) (J) © n (J) CD CD CD © 
• ® CD CD CD © 
• (J) CD CD CD (!) JO (J) CD Q) Q) © 
., (J) CD CD CD © 
II (J) CD CD Q) © 
a (J) CD CD Q) © 
M (J) CD Q) (J) © 
• (J) CD Cl> CD © 
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-
I HOW MUCH WERE YOU DISTRESSED av. ~~~~~ '#i ~ • ':.. \~ 1;. .. ,. ·~.. ..,. • ... 
! 31. FHlin9 other• do not underat8nd you or ere un1ym11e1l'let1c 31 @ CD © © © 
37. Feelint tttet people•,. unfnendly or dlalill• vou 37 @ CD © © <D 
31. Hevin9 to do tl'lint• very alowlY to inaure correctneH 31 @ CD © © <D 
31. Heen poundiftl or recintl 38 @ CD © CD <D 
40. N•uMa or upMt atomecl'I .ao @ CD © CD <D 
41. F•llntinteriortootMra 41 © © © CD (!) 
42. So,.neu of yourmu.clet 42 © © © CD <D 
43. FMlint "'8t youaNwalCMd ortallled about lllyodten 43. '© CD (b CD <D 
44. Trou..ie fallinv • .... P .... © CD © © <D 
41. HeWletodlectlanddclulMe-c:'-11 wltetvoudo ... © © CD CD <D 
41. Difficulty mellift9 deciaion• ... © CD © CD <D 
47. F ..... .,,.., to tNwlon IMIMa. ...., • .,..or ,,.in• 47 "© CD (J) CD <D 
41. Troubte 9enint vour lllrHlh 41 © CD (J) CD '® 
41. Hotorcotd ....... •• © © CD Q) © ;o. Haviftt to evotcl cenain thin9a. olacaa. or ectivitiH beceuM they frithten vou 10 © <D © CD <D 
11. VourmNldt .... ..._. 11 © .<D (J) Q) <D 
12. Numltneu ortin91int in pane of your lllody 12 © <D © CD <D 
13. A lump In vour tllroet 13 © CD © Q) (!) 
14. Feelint no...-. aDout the future 14 © © © CD <D 
II. Troulllewioentratinl II © CD (J) CD <D 
... F•llft9 _...in pane of your body .. © <D © Q) <D 
17. 
,..... ___ up 
17 © Q) (J) CD ® 
II. HNVYffftint• in vour•rm• or let• .. © <D CD CD <D 
II. TMutfltaot ...... •d""8 II © (j) Q) Q) <D 
10. aw ... -. 10 © <D (J) CD © 
'1. ,.....UMMYwllen ....... a,._tchin9ortellinfaboutyou ., © CD Q) (J) <!) 
12. HeWle tll_,.tt .. tllat .,. not vour- 12 © <D © CD <D 
13. ........................................... 13 © CD (J) CJ) (!) 
14. AwHeftiftginlM•rtymornint 14 © <D CD CD © 
II. ........................ ection.IUCh •••ouc:hint. coundnt ........... II © (j) (J) Q) (!) 
II. Sleep tllatia ......_ordlnurtled II © <D (J) Q) © 
17. ............................... 17 © CD (J) (J) (!) 
II. HeWle ideuorMllof8tllatotlleredonotlMN II © (j) (J) © (!) 
... ,........, .... _ ..,, ........... •• © CD (J) Q) (!) 70. , ................................. "' .... t•movie 70 © CD (J) (J) © 
71. ,...... .................. 71 © CD Q) (J) © 
72. . ........ .,.., ........ 72 © (j) CD Q) © 
73. ,...... ........... ~ ............... d ...... inpuMo 73 © Q) (J) CJ) (!) 
74. Getdntlnto ...................... 74 © (j) (J) Q) © 
71. ,..... ............ ,.. .. left ..... 71 © Q) Q) Q) (!) 
71. C>tllannot...,...,_......,...,ltforvourachievernen .. 71 © Q) CD Q) © 
77. ,.....leftaly ........... ,.. ...... ,..... 77 © CD (J) CJ) © 
78. ,..... • ......_,_oouldn'tlltedll 71 © (j) (J) (i) © 
71 . .. .. ....... , ... _ 79 © CD Q) CJ) © 
ao. n.........,t1tat ............ lladi91olntltoha11P9ntoyou ao © (j) (J) (i) © 
81. ......................... ., (i) CD (J) Q) © 
12. , ................................... 82 Ci) (j) (J) CD © 
13. ,..... ......... - ................... lfyoulettllaln u .(I) CD Q) CJ) (!) 
14. HeWletllout .... about•• tllat .......,you a lot ... © (j) (J) CD © 
... Tlleldaa .... .,.. ................. ..,""" .... • .(i) © Q) Q) (!) 
·II. Thoutft'9and ....... otafnttt..-.netuN •• © Q) CD Q) © 87. Tlwldaa ... __..... .. --. ........ _... vourltody WI. G) CD Q) Q) (!) 
II . .__ ............................ •• © Q) CD Cf) © 
... ............... 
-
a> CJ) (I) (I) © 
, IO. Tlwideat1tat...-dlll19le-....wtdl'IOUl'mind IO (!) Q) . CJ) Cf) © 
APPENDIX E 
Pretest Questionnaire 
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PRETEST QUESTIONS 
The following are questions concerning general 
information about Breast Cancer. Please read them 
carefully and circle TRUE or FALSE for each one. 
( 1) TRUE FALSE 
(2) TRUE FALSE 
(3) TRUE FALSE 
(4) TRUE FALSE 
(5) TRUE FALSE 
(6) TRUE FALSE 
(7) TRUE FALSE 
Over 70% of all breast cancers 
occur in women who are older than 
50 years of age. 
Having a child at a younger age 
(under 30) increases the risk of 
developing breast cancer. 
There is some evidence that breast 
cancer is "catching" (contagious). 
The longer a woman has periods 
(number of years) the more prone 
she is to developing breast cancer. 
Seventy percent of women who develop 
breast cancer have no known family 
history of the disease. 
Women who have their 1st full-term 
pregnancy after age 30 have less 
risk of developing breast cancer. 
Birth control pills can reduce the 
risk of developing breast cancer. 
Please turn to next page. 
(8) TRUE FALSE 
(9) TRUE FALSE 
( 10) TRUE FALSE 
( 11) TRUE FALSE 
(12) TRUE FALSE 
( 13) TRUE FALSE 
(14) TRUE FALSE 
(15) TRUE FALSE 
( 16) TRUE FALSE 
Fibrocystic changes in the breast 
increase the risk of developing 
breast cancer. 
A woman has a greater chance of 
developing breast cancer if her 
sister has breast cancer rather 
than her mother. 
Drinking alcohol, even in moderate 
amounts, may increase the risk of 
developing breast cancer. 
Participating in vigorous athletics 
at an early age can reduce the risk 
of developing breast cancer. 
Breast self-examination (BSE) is 
recommended on a monthly basis for 
all women over age 20. 
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The best time to perform BSE is just 
before the time of your period. 
Fifty percent of lumps found on a 
mammogram are too small to be felt. 
Screening for breast cancer by 
mammography should begin after age 50. 
Breast cancer tends to develop at an 
earlier age (before age 50) in women 
with a family history of the disease. 
( 1 7) TRUE FALSE 
( 18) TRUE FALSE 
( 19) TRUE FALSE 
(201 TRUE FALSE 
(21) TRUE FALSE 
(22) TRUE FALSE 
(23) TRUE FALSE 
(24) TRUE FALSE 
(25) TRUE FALSE 
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Breast cancer becomes less common as 
women get older. 
Women with a mother or sister with 
breast cancer have a 2 in 10 or 20% 
chance of developing the disease in 
their lifetime. 
Women with a family history of breast 
cancer have equal to or slightly 
better chance of survival than women 
with breast cancer without a family 
history. 
Every woman between 35 and 40 years 
of age should have a baseline 
mammogram. 
If a mother has breast cancer, then 
all of her daughters will develop 
the disease as well. 
The average woman without a family 
history of breast cancer has a 10% 
or 1 in 10 chance of developing 
breast cancer in her lifetime. 
The majority of American women 
perform Breast Self-Examination 
every month. 
Unless breast cancer runs in her 
family, a woman does not need to 
do Breast Self-Examination (BSE). 
A woman does not need to get a 
mammogram unless her physician 
recommends the test to her. 
APPENDIX F 
Posttest Questionnaire 
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POSTTEST QUESTIONS 
The following are questions concerning the information 
discussed in the twc classes that you attended. Please read 
them carefully and circle TRUE or FALSE for each one. 
Please return this to Joan before leaving the class tonight. 
(1) TRUE 
(2) TRUE 
(3) TRUE 
(4) TRUE 
(5) TRUE 
(6) TRUE 
(7) TRUE 
FALSE 
FALSE 
FALSE 
FALSE 
FALSE 
FALSE 
FALSE 
Over 70% of all breast cancers occur 
in women who are older than 50 years 
of age. 
Having a child at a younger age 
(under 30) increases the risk of 
developing breast cancer. 
There is some evidence that breast 
cancer is "catching" (contagious). 
The longer a woman has periods 
(number of years) the more prone 
she is to developing breast cancer. 
Seventy percent of women who 
develop breast cancer have no known 
family history of the disease. 
Women who lhave their 1st full-term 
pregnancy after age 30 have less 
risk of developing breast cancer. 
Birth control pills can reduce the 
risk of developing breast cancer. 
(8) TRUE FALSE 
(9) TRUE FALSE 
(10) TRUE FALSE 
( 11) TRUE FALSE 
(12) TRUE FALSE 
(13) TRUE FALSE 
(14) TRUE FALSE 
(15) TRUE FALSE 
( 16) TRUE FALSE 
Fibrocystic changes in the breast 
increase the risk of developing 
breast cancer. 
A woman has a greater chance of 
developing breast cancer if her 
sister has breast cancer rather 
than her mother. 
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Drinking alcohol, even in moderate 
amounts, may increase the risk of 
developing breast cancer. 
Participating in vigorous athletics 
at an early age can reduce the risk 
of developing breast cancer. 
Breast self-examination (BSE) is 
recommended on a monthly basis for 
all women over 20 years of age. 
The best time to perform BSE is 
just before the time of your period. 
Fifty percent of lumps found on a 
mammogram are too small to be felt. 
Screening for breast cancer by 
mammography should begin after 
age 50. 
Breast cancer tends to develop at 
an earlier age (before age 50) in 
women with a family history of the 
disease. 
( 1 7) TRUE FALSE 
(18) TRUE FALSE 
( 19) TRUE FALSE 
!20) TRUE FALSE 
(21) TRUE FALSE 
122) TRUE FALSE 
(23) TRUE FALSE 
(24) TRUE FALSE 
(25) TRUE FALSE 
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Breast cancer becomes less common as 
women get older. 
Women with a mother or sister with 
breast cancer have a 2 in 10 or 20% 
chance of developing the disease in 
their lifetime. 
Women with a family history of breast 
cancer have equal to or slightly 
better chance of survival than women 
with breast cancer without a family 
history. 
Every woman between 35 and 40 years 
of age should have a baseline 
mammogram. 
If a mother has breast cancer, then 
all of her daughters will develop 
the disease as well. 
The average woman without a family 
history of breast cancer has a 10% 
or 1 in 10 chance of developing 
breast cancer in her lifetime. 
The majority of American women 
perform Breast Self-Examination 
every month. 
Unless breast cancer runs in her 
family, a woman does not need to do 
Breast Self-Examination (BSE). 
A woman does not need to get a 
mammogram unless her physician 
recommends the test to her. 
PLEASE READ CAREFULLY AND ANSWER ALL OF THE QUESTIONS. 
(26) What percentage best describes YOUR chance of 
developing breast cancer some day? 
Answer from 0 to 100% 
(27) What percentage best describes the AVERAGE woman's 
chances of developing breast cancer some day? 
Answer from 0 to 100% 
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EVALUATION OF EACH CLASS 
(1) Has the information been helpful toward a better 
understanding of breast cancer? 
1 
Of Little 
Help 
2 3 4 5 
Extremely 
Helpful 
(2) Has the information about breast cancer been 
TAUGHT in an understandable fashion? 
1 2 3 4 
Confusing 
5 
Very 
Understandable 
(3) Would you like to hear more about breast cancer? 
1 
Absolutely 
Not 
2 3 
Possibly 
4 5 
Can't wait 
to hear more 
(4) Please feel free to add any additional comments 
or suggestions about the class. 
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SCL-90-R 
. . 
INIT"UCTIONI: 
... ia. lat flf ~ ............. _ ............. 
_..._ .................. -" wutwfully. ANrYoU 
...,,. ............. fll 111- flf ... _... .......... 
.. fillll _.._ ........ HOW MUCH DISCOMFORT 
THAT l'tlO•LIM HAI CAUllD YOU DURING THE 'AIT 
WIEK INCWDING TODAY .... fl! 9llfy - _..,,... 
...... ,., ... .,....... ..... not - ."' ....... ",_ 
....,....,..,.. ....... _.,..,, ....... fl! ........ "UC!"'-
........................ Mfinnlftg. and ff you haw My.-· 
................. tMMician. 
HOW MUCH Wl"I 
YOU OISftHllD IY: 
-
HX 
-
MAI.I 
0 
PIMALI 
0 
-
HOW MUCH WIRE YOU DllTREUED 8Y: 
1. H11i111._ 
2. ,._,,.__,or.,...._ in8ide 
a. 111111111..., ... ._, .. 'llt.....,...dllitwon'tleew.,..mlM 
... ,.........., ...... 
I. .... ., ............ ., ....... 
I. ,...,.........,., ...... 
7 . .............................. .,.. .......... 
•• 
,_.,.. otMn •N to Mame for INiet of,_, tnHll*tl 
•• 
T..-.. ................. 
10. Wonted alMMlt .. 1111•• or ca19'1111WU 
11. ,...... ....,.....,. .,......_. 
12 . ............... ., ..... 
11 . ............... .,..._., ......... 
1•. ,_.,..low ln-.Y or..._.. ..... 
11. "'-""'., ...... ,.. ... 
11. ................ .....,,..,.. ........ , 
17. T ......... 
11. ,...,.. .... _,..,.. __ .__. 
11. ,.., ........ 
20. CfYiftl Mally 
11. ...... atty.,...., ................. 
zz. ,...... ..................... 
u. luili111lr--'fw•-
2•. T....., ............. ,_ ................ 
ZI . ..................... ,... ........... 
21 . ...... ,......, ......... 
27 . ................. 
21. ,...... ____ ... .....,.. ......... 
ZI . ............ 
ao . .......... 
11 . ....................... 
n. ......................... 
n . .............. 
M. y_,........__.........,""" 
"· 
o....r,..... ..... "'.,.. ,.._.. .......... 
iaonard 11111. Detoplil. Ph.D. 
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NAMI: 
LOCATION: 
IDUCATION: 
lllA"ITAL IT&TUI: llAll..:..llP-JlllV-WID._.__ 
DATI ID. AGE 
-
DAY nM -·R 
VlllTllU1181": ---
1 O> Q) Q) Q) 0 
2 CD (i) Q) (J) 0 
I O> Q) (I) Q) 0 
.. O> CD (I) (J) 0 
I (!) Q) (I) Q) © 
I (!) CD (I) CD 0 
7 O> CD (I) CD © 
I O> CD (I) Q) © 
• (!) Q) (I) (I) © 10 O> CD Q) Q) 0 ,, O> Q) (I) (I) © 
11 (!) CD CD Q) 0 
11 (!) CD (I) CD © ,.. O> CD Q) Q) © 
" 
O> (J) (I) CD © ,. O> CD (I) Q) © 
17 O> CD (I) CD © 
" 
® CD (I) Q) © ,. O> CD (I) Q) © 
zo O> (i) Q) CD © 
11 O> CD (I) CD © 
IZ ® CD (I) CD © 
n O> CD (I) CD © 
1• (i) CD (I) CD © 
• O> Q) (I) Q) © 
• O> CD Q) CD © 27 O> CD (I) CD © 
• ® CD Q) CD © 
• O> CD (I) Q) (!) 
• O> CD Q) CD © ., O> (J) (I) Q) 0 
II O> CD (I) CD © 
D $ (I) (I) CD © 
M O> CD CD CD © 
• $ CD (I) CD © 
159 
. 
I HOW MUCH WERE YOU DISTRESSED BY. ~-~~~ ... ~ .-:.."\ .. ... . \. 1; ~.. -,., --.. '•. 
! 31. FHhng others do not understand you or are un1vmpathet1c 31 @ <D © © 0 
37. Feelint tha1.....-eare unfriendly or dilllll• vou 37 @ <D (J) (J) © 
31. Having 10 do thing1 very llowtv to 1n1ure correctne11 31 @ <D © © © 
39. Hun poundinf or racing 39 @ <D (J) © © 
•o. Nau•• or UPMt llOIWMCh 
'° 
@ <D © © © 
41. F•lint inferior to olMrl 41 © © (i) © @ 
42. Sorene11 of your muacle1 42 © (J) (J) © © 
43. Feeling 1tlllt you are watcfled or tallied about by others 43. . (!) (J) Q') © © 
44. Trou.,_ falling ....... 44 © <D © © © 
41. H8Wtt toc:Mcll anddouiMe-checll wftllt you do .. (i) CD (i) © © 
... Dlfflcutty rnelling deci-1 41 © © (i) © © 
47. Feeling etreid to 1n1we-11u-. aullwaya, or train• 47 "© © © © © 
I 41. Trou.,_ getting your bruth .. © CD (i) © '© 
41. Hotorcoldapalla 41 © CD (i) (j) © 
50. Haviftf to avoid cenain thing a. placH. or •ctivitiH llecauM they frighten vou 10 © © © © © 
11. YourlNndg ..... MaM 11 © '© (i) © © 
152. Numltneuorting""' in pane of your body 12 © © (i) © © 
13. A hllR• In yourdtPMt 13 © © (i) © © 
54. F•ling hope .... •bou1 the future 54 © © (i) © © 
II. T,.....eonoantN*'f II © CD © © © 
... F•lint-H In panaof your body II © CD (J) CD © 
17. ,...... .... ., ....... 17 © CD <D CD © 
... HNvyfffffng1in yourann1 or let• II © CD (i) © © 
II. ,,....._ ............. II © CD <D © © 
IO. Owreadng 10 © CD (J) (i) © 
11. ,......uneuy ............ ,._ .... ,. ........ ltoutyou 
" 
© <D <D CD C!) 
12. Haviftf tllouthtatllatarenotvour- 12 © CD (J) (i) © 
u. HaWtl...-ta .... t,lnjuN,or ....... aomaone a © CD CD CD @ 
14. •-llanint ill dteNrtymornint 14 © CD (i) © © 
... ....._.,..... ... ..,...actioft11UChaatouchlnt.coundnt.orwaahtng II © CD <D CD © 
... sa..11 ttllltia rntleuordiaturlled •• © CD CD (j) © 17. " ................. _... ...... 17 © <D CD (j) C!) 
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APPENDIX G 
Final Questionnaire 
Bonnie Taylor, R.N., M.A. 
3024 N. Kenmore 
Chicago, Ill., 60657 
312 935-9740 
Dear 
26 May 1992 
Hope you have not forgotten who I am! ! This is the 
final questionnaire for the Breast Cancer Study for which 
you agreed to participate. Once again, please answer ALL 
questions and return this packet to me in the envelope 
enclosed as soon as possible. If you would like, I will 
mail the results of this study to you as soon as they are 
available. If you did not attend the formal classes and 
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would like to, you will have an opportunity to do so after 
all the final questionnaires have been returned. If you 
have any questions, please do not hesitate to give me a 
call. I greatly appreciate your continued cooperation with 
this study. 
Gratefully yours, 
Bonnie Taylor, R.N., M.A. 
Please check if you: 
would like to attend the two, two-hour classes. 
would like to receive a summary of the results of 
this study. 
(1) Since the time you agreed to participate in this 
study, (approximately 6-12 months ago), have you been 
to a physician for a Pap Test? NO YES 
(2) If yes, approximately when 
(3) What were the results of the Pap Test? 
(4) Since the time you agreed to participate in this 
study, (approximately 6-12 months ago), have you had 
a Mammogram? NO YES 
(5) If yes, approximately when 
(6) What were the results of the Mammogram? 
(7) If no, do you have an appointment for one? When? 
(8) Do you plan to get a Mammogram? NO YES 
(9) How many Mammograms have you had in your life? 
(10) Since the time you agreed to participate in this 
study, have you performed Breast Self-Examination? 
NO YES 
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(11) If yes, how often do you perform BSE? 
~~~~_More than once a month 
~~~~-Once a month 
~~~~_Every other month 
~~~~-Four times a year 
~~~~-Twice a year 
~~~~_Once a year 
~~~~-Not at all 
(12) If you do not perform BSE, please describe what 
stops you?~~~~~~~~~~~~~~~~~~~~~~~ 
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(13) From the time you agreed to participate in this 
study, has anyone taught you Breast Self-Examination? 
YES 
~~~-
(14) If yes, who taught you: Nurse 
Other 
Doctor~~~-
(15) From the time you agreed to participate in this 
study, have you had a biopsy of your breasts? 
NO YES 
(16) If yes, what were the results of the biopsy? 
1171 From the time you agreed to participate in this 
study, have you been to see a physician for a 
check-up? NO YES 
(18) If yes, what was the reason? 
(19) From the time you agreed to participate in this 
study, have you altered your diet in any way? 
NO YES 
(201 In what way? Please check the appropriate column. 
Calorie Intake 
Fat Intake 
Other changes 
Increased Decreased No Change 
(21) From the time you agreed to participate in this 
study, have you read any books related to breast 
cancer? NO YES __ _ 
(22) If yes, which one/ones? 
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(23) From the time you agreed to participate in this 
study, have any close relatives been diagnosed with 
breast cancer? NO YES 
(24) If yes, please comment. 
(25) What percentage best describes YOUR chance of 
developing breast cancer some day? 
Answer range from 0 to 100% 
(26) What percentage best describes the AVERAGE woman's 
chances of developing breast cancer some day? 
Answer range from 0 to 100% _____________ _ 
(27) From the time you agreed to participate in this 
study, is there anything that you've done to become 
more informed about breast cancer? NO YES 
(28) Please comment. 
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APPENDIX H 
Didactic Course 
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DIDACTIC COURSE OUTLINE 
I. Introduction to General Cancer Information 
II. Information Specific to Breast Cancer 
A. Incidence of Breast Cancer 
B. Risk Factors 
1. Age 
2. Family History 
C. Hormonal Risk Factors 
D. Fibrocystic Changes 
E. Life-style Factors 
1. Alcohol consumption 
2. Diet 
III. Preventive Health Behaviors 
A. Physician Breast Examinations 
B. Mammography 
C. Breast Self-Examination 
IV. Recommended Reading 
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Thank you for participating in these classes. You 
are all here because you know someone who is living with 
breast cancer. We recognize that this is not an easy 
task - hearing about breast cancer and dealing with this 
information which can increase anxiety. 
Classes began with a RELAXATION TAPE. 
How much do you know about breast cancer? 
you're like most women probably not enough. 
Well, if 
Just the 
slightest suggestion of these two words can bring ripples 
of anxiety, fear and denial into most of us. The major 
goal of these two classes you will be attending is to 
increase your knowledge about breast cancer. Specifically, 
increase your knowledge about your own risk and increase your 
habit of practicing health behaviors to minimize your risk. If 
you remember only one thing about breast cancer it should be 
that vour best protection is EARLY DETECTION. 
What causes breast cancer? We know that breast cancer 
develops from the abnormal growth of breast tissues. It is 
frustrating that at this time we do not know what causes the 
abnormal growth of these cells. Possible factors that may 
play a part in the development are HEREDITY and HORMONES. One 
way to help counter the frustration is to become familiar with 
what we DO KNOW about breast cancer. WHAT IS CANCER? 
Cancer is not one disease but many different 
diseases. There are more than 100 different types of 
cancer and several different types of breast cancer. 
They all have one thing in common: abnormal cells that 
grow and replace or displace normal healthy cells. 
Healthy or normal cells that make up the body's 
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tissues grow, divide and replace themselves in an orderly 
fashion. This is a normal on-going process that keeps the 
body in good working condition. However, sometimes cells 
lose their ability to control their growth, by growing too 
rapidly and without any order. This result can lead to too 
much tissue and tumors are formed. These tumors can be 
benign or malignant. 
SLIDE ONE BENIGN TUMORS 
- Grow in an orderly and timely fashion. 
- Are not cancerous. 
- Do not spread to other parts of the body. 
- Are seldom a threat to one's life. 
SLIDE TWO MALIGNANT TUMORS 
- Grow faster than normal cells. 
- Grow in an "out of control" fashion. 
- Are cancerous. 
- Spread and REPLACE or DISPLACE healthy tissues 
and organs. 
Any questions about the slides so far? 
HOW DOES A TYPE OF CANCER GET IT'S NAME? 
INCIDENCE 
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The American Cancer Society estimates that in 1991 
approximately 175,000 American women will develop breast 
cancer. This number has increased significantly from 
155,000 in 1990. This revised estimate means that the risk 
for developing breast cancer rises from one in ten women 
to one in nine women (ACS, 1991). 
for this increase include: 
Several explanations 
(1) the "baby boom" generation is getting older, 
(2) a longer life expectancy for women, 
(3) improved techniques in mammography, 
(4) increased use of early detection screening methods, 
(5) to be honest, there is a true increase in incidence. 
Breast cancer becomes more common as women get older. 
Over 70 percent of all breast cancers occur in women who 
are older than 50, and less than 2 percent of all breast 
cancer occurs before 30 years of age (Lynch, Watson and 
Conway, 1988) . According to American Cancer Society 
statistics, in 1987 the average white woman's risk for 
developing breast cancer was about 2 percent from birth 
to 50 years of age and only 6 percent from birth to 70 
years of age. It might be more accurate to state from 25 
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to 50 or 70 rather than birth, since breast cancer generally 
does not occur in women less than 25 years of age. Only if a 
woman were to live to age 110 would her risk be 10 percent 
ercent. More than one-third of the risk is expressed after 
75 years of age and more than one-half of the risk is after 
65 years of age. The average black woman's risk is a little 
lower, about 8 percent to age 110, but the risk is rising 
rapidly and approaching that of white women. 
RISK FACTORS 
"Risk factors" describes a term that refers to factors 
that are identified that make some people more susceptible 
than others to a particular disease. For example, people with 
high blood pressure have a greater chance of having a "stroke" 
than those with low blood pressure. Individuals who smoke have 
a greater chance of developing lung cancer than those who do 
not smoke. Individuals with a high cholesterol level have a 
greater chance of developing heart disease than those with 
low levels of cholesterol. 
Before discussing specific risk factors for breast 
cancer, let's spend a few moments clarifying several 
different types of risks. 
ABSOLUTE RISK is the ratio of the number of events 
to a total population. For example, absolute risk of 
breast cancer is the ratio of number of times breast cancer 
occurs in the general population. 
two possible ways: either as 
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It is usually discussed in 
the number of cases per a 
specified population, for example, 50 cases per 100,000; or 
as a CUMULATIVE risk up to a particular age. This CUMULATIVE 
RISK can be misleading. This is the common "1 in 10" lifetime 
risk for white women that is used so often. 
Let's explain the "1 in 10" lifetime risk. Dr. Susan 
Love describes absolute risk or the "1 in 10" lifetime risk 
very well in her "Breast Book". First of all, it does not 
mean that if there are 10 women in a room that 1 of those 
women will get breast cancer. There are several assumptions 
that are made when discussing the cumulative number, that are 
not necessarily true for all women. The assumptions include: 
(1) The absolute risk of getting breast cancer is assumed to 
be the same for all women (Love, 1990). 
(2) It is assumed that all women will live to be 110 years of 
age (Seidman, Nushinshi, Gelb, et al, 1985). 
What the number actually means is that IF you take 10 
white women at age 25, and IF they all start with an equal 
risk of getting breast cancer, and IF they all live to 110, 
the chances are that one of them will get the disease during 
her lifetime. The problem with this "1 in 10 " number is that 
it will overestimate the risk for women with NO risk factors 
and underestimate for the women with risk factors (Love, 1990). 
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SEE HANDOUT 
Another method for looking at risk is ATTRIBUTABLE 
RISK. This concept looks at the amount of disease in the 
population that could be prevented by altering risk 
factors (Love, 1990) . For example, according to Dr. Miller 
(1987) the total fat in one's diet may possibly account 
for 26-27 percent of breast cancers. Stated another way, 
the attributable risk is that one in four women with 
breast cancer possibly could have prevented the disease 
by altering one's eating habits. However there might still 
be 75 percent of breast cancers or three out of four that 
would not be affected by decreasing dietary fat (Love, 1990). 
RELATIVE RISK is another type of risk. This is a 
comparison of all the incidence of breast cancer among 
women with a particular risk factor to women without a 
particular risk factor. 
THE NEXT COUPLE OF SLIDES WILL SUMMARIZE THE RISK FACTORS 
ASSOCIATED WITH BREAST CANCER. PLEASE FOLLOW ALONG WITH THE 
SLIDES AND YOUR HANDOUT. SLIDE 3 
MAJOR risk factors for developing breast cancer include: 
(1) increasing age, 
(2) history of breast cancer in a mother or sister, 
(3) a previous history of cancer (although this is now 
thought to be a secondary risk factor). 
SLIDE 4 
SECONDARY risk factors include: 
(1) history of breast cancer in a maternal or paternal 
grandmother or aunt, 
(2) nulliparity (not having had children), 
(3) having a first child after 30 years of age, 
(4) early menarche and late menopause, 
(5) history of atypical hyperplasia. 
(6) moderate amounts of alcohol intake before 30 years 
of age. 
WE WILL GO THROUGH EACH OF THESE AS WE MOVE ALONG 
SLIDE 5 
POSSIBLE risk factors include: 
(1) obesity or high intake of animal fat, 
(2) estrogen replacement therapy, 
(3) radiation exposure at an early age. 
It is important to keep in mind that at this time, 
there is no known cause of breast cancer. Presently, 
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there are many different factors that fit into the breast 
cancer puzzle and that either increase or decrease a 
woman's chances of developing breast cancer. 
FAMILY HISTORY 
One of the major categories for risk factors is 
genetic. If there is a family history of breast cancer, 
women tend to either overestimate or underestimate their 
chances of developing the disease. It is hoped that these 
classes will correct any misconceptions about your risk 
for breast cancer. 
Dr. David Anderson at M.D. Anderson Cancer Center 
has identified two different types of family histories. 
In the first type of family, Type I, breast cancer is 
present in a single generation, for example, two or more 
sisters are affected, but their mothers and daughters are 
not. In the second type of family, Type II, breast cancer 
is present in two or more generations, for example, a 
grandmother and mother or a sister and mother are 
affected (Kelly, 1991). 
In the past it was thought that there were only two 
kinds of breast cancer: one that is inherited and one that 
is not. According to Dr. Lynch and colleagues (1988) pure 
hereditary cancer is quite rare. Between 5 -7 percent of 
all breast cancers will fall into this category. Present 
thinking is that there is another group that appears to be 
more common than the family type and is called SPORADIC. 
In fact, most (70 percent) of breast cancers are 
called SPORADIC, meaning there is no genetic or familial 
association that can be identified. This means that only 
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30 percent of patients with a diagnosis of breast cancer 
have a close relative with the disease. Even though this 
is a minority of the women with breast cancer, this is an 
important group because they can be identified and taught 
in order to increase awareness of risk and awareness of 
preventive health behaviors that can lead to EARLY 
DETECTION. Early detection leads to higher CURE rates. 
The average American woman has a 10 percent or 1 in 10 
chance of developing breast cancer in her lifetime. If a 
woman has a mother OR sister (first-degree relative) with 
breast cancer than her chances of developing the disease 
increase to 20 percent or 1 in 5 (Anderson & Badzioch, 
1985). This chance is NOT greater if the sister has the 
disease rather than the mother. This number will depend 
on the mother's age and menopausal status at the time of 
her diagnosis and whether she had unilateral or bilateral 
disease (Sattin, Rubin & Webster, 1985). Generally 
speaking, the risk increases if the mother develops breast 
cancer at an earlier age (under 50), which usually means 
that she is premenopausal and if she developed breast 
cancer in both breasts. 
A woman with a mother AND sister with breast cancer 
has a 50 percent or 1 in 2 chance of developing breast 
cancer in her lifetime. Because of this potential 
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increase in risk, women in this category may require 
earlier education about breast cancer which emphasizes 
early detection. 
If a woman with a family history of breast cancer 
develops the disease, and if the breast cancer is found 
early then the chances of cure are 90 percent. There is 
a tendency for women with a familv history of breast 
cancer, to develop the disease at an earlier age (between 
20 -44 vears of age) than that of the general population 
which is between (50 -59 years of age). However women with 
a family history of breast cancer have a survival equal to 
or better than that of other patients with breast cancer 
without a family history (Anderson & Badzioch, 1985). 
One aspect to emphasize is that having a family member 
with breast cancer does not guarantee that you will develop 
the disease. If a woman has a mother with breast cancer, 
this does not guarantee that she will develop the disease. 
It is important for women to be fully informed about 
their family's disease history. A first step in 
determining this information is to "map out" a family tree. 
This is called a GENOGRAM. We thought it might be an 
interesting and educational exercise to give you a homework 
assignment between these two classes. 
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I'm going to pass around the homework assignment. 
Let's go over this together so that everyone is clear about 
the assignment. This is an example of a Genogram. Let's 
talk about the page with Figure One. 
First begin talking to other family members, 
preferably older family members and dig through old family 
records to determine illnesses and perhaps causes of 
death of past family members. 
HORMONAL RISK FACTORS 
The next risk factor to discuss is probably the most 
obvious risk factor: hormonal risk factors. We DO know 
that hormones play an important part in breast cancer 
because it's the most common type of cancer in women and 
is rare in men. We really DO NOT understand the specific 
role that hormones play, but we do know that there is a 
connection between age and the length of time that one 
menstruates. That is the longer one has periods (number 
of years), the more prone she is to developing breast 
cancer. For example, women who begin their periods before 
age 12 and do not begin menopause until after age 50 have 
a greater risk of developing breast cancer. 
According to Dr. Henderson (1990) the circumstantial 
evidence linking changes in normal menstrual function with 
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the probability of developing breast cancer is overwhelming. 
Girls who have late onset of menarche are also likely to 
have a delay in having regular ovulatory cycles, and this 
delay may have a protective effect independent of age at 
menarche. The risk of developing breast cancer is almost 
twice as high among women who start their periods early and 
begin having regular cycles compared with women who have 
early onset of menarche and a delay of 5 years or more until 
the beginning of regular cycles (Henderson, 1990). 
One major theory being examined is that anything that 
delays the age of menarche or especially the frequency of 
regular ovulatory cycles will decrease a woman's risk. For 
example, both strenuous physical activity and malnutrition 
are known to decrease regular ovulation. In one study the 
incidence of breast cancer was much lower in women who 
participated in high school and college athletics (Frisch, 
Wyshak, Albright, et al, 1985). From past studies several 
hypotheses or theories have emerged: 
( 1) events in the adolescent years may be critical in 
affecting the 1 i felong chances of developing breast cancer. 
(2) Interventions that slow menarche or that decrease the 
frequency of regular periods throughout a woman's lifetime 
may substantially reduce the risk of getting breast cancer. 
When we talk about HORMONES we're primarily focusing on 
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ESTROGENS. Estrogens are one of two hormones produced by 
the ovaries and are the substances that make us women, for 
example, estrogens help in the development of breasts. 
Pregnancy can also affect the potential development of 
breast cancer. Women who have their first full-term 
pregnancy before age 20 have less risk of developing 
breast cancer than women who are over 30 when thev have 
their first child. Women who have no children are also at 
risk, but the risk is less than women who have their 
children after age 30 (Lynch, Watson, Conway, et al, 1988). 
At this time we have no scientific answers about 
how the interaction of hormones relates to breast cancer. 
It appears unlikely that hormones "cause" breast cancer. 
However there are several interesting theories that we 
might briefly discuss. One possible explanation is that 
between the time a girl begins to menstruate and the time 
of her first pregnancy the breast tissue is extremely 
sensitive to carcinogens. For example, diet, alcohol 
and radiation exposure appear to have an effect on 
breast tissue early in one's life rather than later. 
It may be that "developing breasts" may be more 
susceptible to carcinogens than breasts that are 
finished developing. 
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EXOGENOUS HORMONES 
These are hormones taken externally as drugs, 
for example the birth control pill. THere have been 
over 25 studies looking at the relationship between 
breast cancer and oral contraceptives. The vast 
majority of these studies have shown no associations 
between use of "the pill" and development of breast cancer. 
One solid conclusion that CAN be drawn from all of these 
studies is that birth control pills offer no protection 
against the development of breast cancer as was once 
thought. However, at this time evidence supports the 
safety of oral contraceptive use especially when used for 
limited durations of 2 to 4 year periods. The one 
subgroup where evidence exists for an increased frequency 
of breast cancer is women below 20 years of age using the 
pill. 
ESTROGEN REPLACEMENT THERAPY (ERT) FOR POSTMENOPAUSAL WOMEN 
Again the same conclusion can be drawn for prolonged 
estrogen exposure as with oral contraceptives, that ERT 
does not decrease the risk of developing breast cancer. 
The results of the many studies reported are very 
controversial and make it impossible to draw any reliable 
conclusions. We simply do not have enough information to 
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properly inform women about the risks and benefits to ERT 
as they relate to breast cancer development. Overall the 
association of ERT with breast cancer is weaker than the 
association of ERT with endometrial cancer (Henderson, 
1990}. In the end, women must evaluate the risks versus 
benefits of ERT. For example if osteoporosis runs in her 
family, then taking estrogens may be very beneficial 
compared with the unknown risk of developing breast cancer. 
FIBROCYSTIC CHANGES 
Many of you may have heard the term "fibrocystic 
disease" or may have been told that you have fibrocystic 
breasts. In the past ''fibrocystic disease" was a catch 
-all phrase used to describe all sorts of symptoms such 
as breast pain, swelling, tenderness, and discharge. 
It is an outdated term no longer in use because it is 
recognized that pathologically the findings in the breast 
are not a disease but are changes that occur to some 
degree in all of us. Today the preferred term used is 
"fibrocystic changes" which refers to both variations 
in the normal lumpiness of the breast and to changes 
that occur during the menstrual cycle. 
Fibrocystic changes do not in themselves predispose 
an individual to an increased risk of breast cancer. The 
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significance of fibrocystic changes and breast cancer is 
that they may mask an early cancer or make it difficult to 
detect a cancer. 
The subject of "fibrocystic disease" leads to a 
few myths that need to be corrected. It was once thought 
that eliminating caffeine from one's diet would improve or 
eliminate "fibrocystic disease". This is not true. 
Vitamin E has also been recommended to treat fibrocystic 
changes in the breast, however there is no sound 
scientific data to support either of these "so-called" 
solutions. 
LIFE STYLE FACTORS 
Life style risks such as diet, alcohol and certain 
drugs are attributable risks over which we have some 
control. An association (not a cause and effect) has 
been made between high fat intake and the incidence of 
breast cancer. For example, the rate of breast cancer 
in Japanese women is very low and their dietary fat is 
12 to 15 percent of their calorie intake. Compare this 
with American women who have a greater incidence of breast 
cancer and their dietary fat is 40 percent of their calorie 
intake. However the incidence of breast cancer increases 
as Japanese women move to the U.S. and begin to Westernize 
184 
their diet and add fat. This picture is especially true for 
the daughters of Japanese-American women (Buell, 1973). One 
theory is that fat intake makes more of a difference when 
the person is young and still growing rather than in an 
older person (Love, 1990). 
However, the relationship between high-fat intake and 
breast cancer is still not based in any sound scientific 
studies. In fact one aspect from the Japanese studies of 
fat content that may confuse the data is that Japanese 
women are typically older (16 years of age) when they 
begin menarche. 
At this time, the fact that a low fat intake is 
recommended for other diseases such as heart disease 
suggests it's a wise idea to cut back on dietary fat. 
Another life-style factor to discuss is alcohol 
consumption. The suggestion has been made that drinking 
alcoholic beverages, even in moderate amounts, may 
increase the risk of developing breast cancer. 
In fact, the link between risk of breast cancer and 
alcohol consumption is probably stronger than that of 
any other environmental correlation. 
An analysis of many studies suggested that about 
13 percent of all cases of breast cancer in the U.S. 
might be attributable to alcoholic consumption 
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(Longnecker, Berlin, Orza, et al, 1988). The results of 
this study showed that the daily consumption of 12 gm of 
alcohol (equivalent of one standard drink of beer, wine 
or liquor) was associated with a relative risk of 1.4 
(a 40 percent increase in the probability of developing 
breast cancer). Three drinks per day would almost double 
a woman's risk (Henderson, 1990). 
An interesting observation that came out of this 
major study was again the association between age and an 
environmental factor. For example, a woman who drank 
less than one alcoholic drink per week while under 30 
years of age had no significant increase in breast 
cancer later in life (after 30), even if her alcoholic 
intake increased to 1 to 2 drinks per day. 
In spite of this information, it is doubtful that 
women will become teetotalers. However, it points out 
another argument that early exposure to environmental 
factors in "developing" breast tissue may contribute 
to the risk of developing breast cancer later in life. 
Adolescence and young adulthood may be the critical time 
period for developing healthy habits that will contribute 
to a longer, healthier life. 
habits might include: 
Several of these healthier 
(1) limiting the fat content in a girl's/woman's diet. 
(2) Maintaining an ideal body weight. 
(3) Encouraging participation in vigorous athletics, 
preferably several years before menstruation (periods) 
begin and continuing in high school and college. 
(4) Alcohol consumption in excess of one or two drinks 
per week should be discouraged before 30 years of age. 
(5) Developing preventive health behaviors for early 
detection of breast cancer is essential for all women. 
These would include: monthly breast self-examination, 
yearly physician breast examinations and routine 
mammography. 
REVIEW PREVENTIVE HEALTH BEHAVIORS 
(Let them do the review for you). 
GO OVER THE NCI MAMMOGRAM PAMPHLET. 
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NOW LET'S WATCH A GOOD VIDEO WITH OUT OF DATE FASHIONS ABOUT 
BREAST SELF-EXAMINATION. 
HOW TO MINIMIZE RISK OF BREAST CANCER 
Dr. Mary Dan Eades uses the concept of the Golden 
Triangle to discuss the three major established methods 
of early detection of breast cancer. These consist of 
yearly physician breast examinations, monthly breast self-
examinations and routine mammography. It is important to 
stress that all three of these methods are used TOGETHER, 
not one in place of another. 
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EARLY DETECTION is the key to increased cure rates 
and survival. It is important to keep in mind that the 
five year survival rate for localized breast cancer 
(Stage 1) has risen from 78 percent in the 1940's to 90 
percent today (ACS, 1990). The survival rate is directly 
related to the size of the tumor. The smaller the tumor, 
the greater the chance for cure. Therefore finding a tumor 
at its earliest possible point is the goal of early 
detection screening methods. 
Physical examination should occur on a yearly basis 
when women visit their physicians for their "Pap test". 
If a breast examination is not done at this time, you 
need to ask for one. A proper breast examination performed 
by a health professional should include feeling the breast 
and underarms with their fingers in order to detect lumps. 
The medical term for this is palpation. 
The health care professional will also be checking 
for "dimpling" of the skin and any possible discharge or 
rash around the nipples. This is a good time to get 
instruction on BSE to verify that you are performing it 
correctly. PROPER BSE is one of the keys to early 
detection. Improper BSE has no preventive benefit. 
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BREAST SELF-EXAMINATION 
Breast self-examination ( BSE) is recommended bv the 
American Cancer Society (ACS) and the National Cancer 
Institute (NCI) on a monthly basis for all women over 
age 20. 
Many women are reluctant to practice BSE. Frequent 
comments by women include: "everything feels like a lump" 
or "my breasts are too lumpy" or "I can not tell what is 
normal or abnormal", and most common, "I don't want to 
check my breasts for fear I might find something". It is 
important to remember that all breasts are lumpy, 
especially before menopause. The best person to become 
familiar with the normal lumps and lumpiness of your 
breasts is yourself. The lumpiness is not abnormal, 
but if there is a change in the normal lumpiness, then a 
visit to your physician is required. 
BSE is a simple and safe procedure without a 
financial cost to women who practice it. Women need to 
keep in mind that breasts come in all sizes and shapes 
and will even change in a woman during her lifetime. 
Your monthly menstrual cycles, pregnancy, childbirth, 
breast-feeding, age, weight, birth control pills and other 
hormones may change the shape, size and feel of your 
breasts. One of the advantages of monthly self-examination 
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is that each woman "gets to know" her breasts and what is 
normal for her and what feels abnormal. 
The best time to practice BSE is 2 or 3 davs after 
the end of your period because your breasts are less likely 
to be swollen or tender. If you no longer have periods, 
then choosing a particular day of the month, for example, 
the first day of the month or a birth date. Being consistent 
is one of the important aspects to BSE. 
There is some controversy as to the benefit of 
practicing BSE. One major argument in favor of teaching 
and encouraging women to perform monthly BSE is based on a 
report by Huguley and Brown (1981). In a study of over 
2000 women they found that the more frequently women 
performed BSE, the more likely BSE was successful as 
being the first method to detect cancer. (It is 
interesting to note that over 95 percent of all lumps 
in the breast are detected by women themselves). 
When cancer was discovered by BSE it was at an earlier 
stage than after all other methods except mammography. 
This finding indicates that the practice of BSE can play 
an important role in EARLY diagnosis of breast cancer. 
There are several areas of concern surrounding the 
topic of BSE. Results from several surveys have found 
that most women know about BSE and understand it's 
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importance, but too few women actually practice BSE. The 
results of these studies found that 95 percent of women 
surveyed know about BSE, 66 percent of the women report 
practicing BSE in one year's time, and 27 percent perform 
monthly BSE, however onlv 13 percent perform BSE correctly 
(ACS, 1973; ACS, 1978; NCI, 1981). The majority of 
American women do not perform BSE. Several factors have 
been reported that may relate to the lack of performance 
of proper BSE. These include: (1) embarassment, 
(2) lack of confidence by women in the actual performance 
of BSE and in knowing the difference between normal and 
abnormal breast tissue, and (3) remembering to do BSE. 
The results of these studies help us to focus on how to 
make BSE a more comfortable health behavior to practice. 
- Let's go through the pamphlet on BSE. 
- Go over basic anatomy at this time from pamphlets. 
NEXT WEEK WE WILL REVIEW THIS AGAIN AND PRACTICE FEELING 
WHAT AN ABNORMAL LUMP FEELS LIKE. 
MAMMOGRAPHY 
Mammography is a radiographic technique (an x-ray) 
that allows one to see the internal structure of the breast. 
It can detect non-palpable (unable to feel) lumps. In 
addition, physicians are able to detect changes in breast 
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tissue that may be an early clue for a cancer that might be 
developing by comparing a current mammogram with an earlier 
one. Eighty-five percent of breast cancers will be detected 
by mammography. Fifty percent of lumps found on a mammogram 
will have been too small for vou or your physician to have 
felt. 
Physicians and nurses recommend mammography because it 
can be very effective at finding cancers at an early stage. 
Unfortunately, most women do not take advantage of this 
preventive heal th behavior and as a result, their breast 
cancers are not found as early as one would hope. Many 
studies have shown that only 37 percent of women over the 
age of 40 have ever had a mammogram. In addition, more 
than half of American physicians fail to recommend routine 
mammograms to their women patients. If your physician does 
not recommend a mammogram then find one who will follow the 
ACS recommended guidelines. 
All women between 35 and 40 years of age should have a 
baseline mammogram. After 40 all women should have routine 
mammograms every 1 to 2 years until age 50. After 50, 
mammography should be done every year. 
PASS AROUND THE MAMMOGRAMS - POINT OUT THE LUMPS 
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In the past there was concern over radiation 
exposure from mammography. Currently, radiation doses 
delivered by modern techniques and equipment are so low 
that the benefits far outweigh the risks. The American 
Cancer Society requires that radiation doses delivered by 
mammography should not exceed one rad. However the 
efficiency of some facilities performing mammograms 
varies, so the American College of Radiology has developed 
a volunteer certification program to assure a safe testing. 
A list of certified facilities can be obtained by calling 
the Cancer Information Service at 1 800 4-CANCER. 
Here's a description of what it's like to get a 
mammogram. It is requested that you not wear deodorant 
or powder the day of your mammogram. First of all, you 
undress from the waist up, put on a gown so that it opens 
from the front. The technician, usually a woman, places 
your breasts between two plastic cold plates and then some 
pressure is applied to flatten the breasts in order to get 
a good, clear picture. This will feel uncomfortable and 
even hurt but will only last a few seconds. Much of the 
discomfort can be avoided if you schedule the mammogram 
during the time in your monthly cycle when your breasts are 
least likely to be tender, sore or swollen. Usually 2 to 4 
views or pictures are taken of each breast. 
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It generally takes a few days to evaluate the 
mammogram. If your physician or nurse does not call you 
with the results, then do not hesitate to call them to 
discuss the results. In fact, it isn't a bad idea to get 
copies of the reports and keep your own medical file at 
home. This will also help you to remember when to schedule 
your next mammogram. 
APPENDIX I 
Course Handout 
COURSE OUTLINE 
A. Course Evaluation 
B. What is Cancer? 
C. Family Genogram - Homework Assignment 
D. Table of Average Risk of Developing Breast Cancer 
E. Major Risk Factors 
F. Health Behaviors to Practice to Reduce the Risk of 
Developing Breast Cancer. 
G. Recommended Reading 
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OUTLINE OF SESSIONS 
This is a general outline of what will be covered in each 
didactic session. I estimate that each class will be an 
hour and one-half in length. 
SESSION ONE 
Introduction to the course 
Relaxation exercise 
What is Cancer 
Incidence of Breast Cancer 
Risk Factors 
Family History 
Review homework 
Preventive Health Behaviors 
Review and "Debriefing" 
SESSION TWO 
Relaxation exercise 
Review from last week 
Go over homework assignment 
Other Risk Factors 
Hormone Factors 
Fibrocystic Changes 
Life-style factors (Diet and Alcohol) 
Overall Review and Debriefing 
Post test 
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Future risk at any one time depends upon the age 
of the woman. Breast cancer becomes more common as women 
get older. 
TABLE 1. 
The Average Risk of Developing Breast Cancer in a Given 
Year in White American Women 
AGE RISK per YEAR 
30 1 in 5,900 
35 1 in 2,300 
40 1 in 1,200 
50 1 in 590 
60 1 in 420 
70 1 in 330 
80 1 in 290 
* adapted from Stamper, Gelman, Meyer & Gross (1990) 
New England Mammography Survey- 1988: 
"Misconceptions of Breast Cancer Incidence", 
Breast Disease, May. 
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TABLE 2. 
FAMILY HISTORY and RISK OF BREAST CANCER 
FAMILY HISTORY 
None 
First-degree relative 
Mother 
Sister 
Mother and Sister 
Second-degree relative 
Grandmother 
Aunt 
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RELATIVE RISK 
1. 0 
2.1 
2.1 
13.6 
1. 5 
1. 5 
* adapted from Sattin, Rubin, Webster and colleagues 
(1985) "Family History and the Risk of Breast Cancer", 
Journal of the American Medical Association, 252, 
pg. 1908. 
MAJOR RISK FACTORS 
FOR DEVELOPING BREAST CANCER 
PRIMARY RISK FACTORS 
- INCREASING AGE 
- HISTORY OF BREAST CANCER IN A 
MOTHER OR SISTER 
- PREVIOUS HISTORY OF CANCER 
SECONDARY RISK FACTORS 
- HISTORY OF BREAST CANCER IN MATERNAL 
or PATERNAL GRANDMOTHER or AUNT 
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- HAVING FIRST CHILD AFTER 30 YEARS OF AGE 
- NOT HAVING HAD CHILDREN 
- EARLY MENSTRUATION and LATE MENOPAUSE 
- HISTORY OF ATYPICAL HYPERPLASIA 
- MODERATE TO HIGH ALCOHOL CONSUMPTION 
- HISTORY of CANCER of the ENDOMETRIUM 
OVARY or COLON 
POSSIBLE RISK FACTORS 
- OBESITY or HIGH INTAKE OF ANIMAL FAT 
- ESTROGEN REPLACEMENT THERAPY 
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PREVENTIVE HEALTH BEHAVIORS 
Pamphlets from the American Cancer Society and National 
Cancer Institute will be given to each woman and gone 
through in class. 
BREAST SELF-EXAMINATION (BSE) 
MAMMOGRAPHY 
HORMONAL RISK FACTORS 
(ll The longer a woman has periods (number of years) 
the more prone she is to developing breast cancer. 
(2) Women who have their first full-term pregnancy before 
age 20 have less risk of developing breast cancer 
than women who are over 30 when they have their first 
child. 
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EXOGENOUS HORMONES 
BIRTH CONTROL PILLS 
(1) Safe to use in 2-4 year periods of time. 
(2) As of present research findings they do not cause breast 
cancer. 
(3) Birth control pills do not protect from breast cancer. 
(4) Women under age 20 using the birth control pill have an 
increased risk of developing breast cancer. 
LIFE STYLE FACTORS TO HELP REDUCE RISK 
(1) Maintain an ideal body weight. 
(2) Limit the fat content in your diet. 
(3) Encourage athletics in girls and young women 
preferably before menstruation begins. 
(4) Discourage drinking more than 1-2 drinks per WEEK 
in women under 30 years of age. 
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(5) Practice EARLY DETECTION guidelines for breast cancer. 
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APPENDIX J 
Homework Assignment 
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GEN OGRAM 
A genogram is a visual picture drawn with symbols to help 
look at our family's roots. This homework assignment is given 
to help you understand your family's health picture. 
Specifically, we want to help you understand your own 
inherited risk for breast cancer. We will use the standard 
genogram symbols. In addition to the basic symbols, you may 
want to draw a double line under your own symbol to 
distinguish yourself from the rest of your family. When 
you've finished drawing the skeleton of your family tree, 
you'll have a diagram that looks similar to Figure 1 in this 
packet. For the purpose of this homework assignment, please 
fill in family cancer histories, especially breast cancers. 
After the classes you may want to go back and fill in other 
health histories such as heart disease or diabetes. We will 
go over the Genograms in the second class, so in order to get 
the most of the class, please come with the assignment 
finished. 
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